1. Introduction {#sec1-molecules-24-02330}
===============

Endophytes are bacterial or fungal microorganisms that colonize a wide variety of plant tissues during at least some period of their lifecycle. Endophytic infection is considered inconspicuous, the infected host tissues are at least transiently symptomless, and the microbial colonization is internal \[[@B1-molecules-24-02330],[@B2-molecules-24-02330]\]. Endophytes have been isolated from all of the studied plant species \[[@B3-molecules-24-02330]\]. However, it has been estimated that only 1--2% of the known 300,000 plant species have been studied for their endophytes \[[@B4-molecules-24-02330]\]. The relationship between the host and the endophyte can have many forms ranging from saprobic to parasitic and from exploitative to mutualistic. Endophytic fungi and bacteria have been shown to improve the health of the host plant by improving the biotic and abiotic stress tolerance due to phytohormone production, and host's nutrient uptake \[[@B5-molecules-24-02330],[@B6-molecules-24-02330],[@B7-molecules-24-02330],[@B8-molecules-24-02330]\]. The endophytes have also been shown to produce toxic chemicals preventing attacks by insects and herbivores \[[@B9-molecules-24-02330],[@B10-molecules-24-02330]\].

Dark septate endophytic fungi (DSE) are often dominant in the roots of tree species \[[@B11-molecules-24-02330]\] and characterized with melanized and septate hyphae. These Ascomycetous conidial or sterile endophytic fungi colonize the roots of many higher plant species widely in the northern hemisphere and are extensively distributed in coniferous boreal forests \[[@B12-molecules-24-02330]\]. The most frequent DSE in natural forest ecosystems in the northern hemisphere belong to the *Phialocephala fortinii* s.l.--*Acephala applanata* species complex (PAC) and up to 80% of fine roots in forest stands can be colonized by them \[[@B11-molecules-24-02330]\]. Studies have shown that DSE and PAC species induce resistance to abiotic stress, accelerate root turnover and mineralization, and suppress root pathogens \[[@B11-molecules-24-02330],[@B13-molecules-24-02330],[@B14-molecules-24-02330],[@B15-molecules-24-02330]\].

The metabolic profiling of endophytes has revealed novel compounds possessing interesting bioactive properties to be utilized in future. For example, during the years 1995 to 2011, at least 313 novel compounds were isolated and identified from bacterial and fungal endophytic microorganisms \[[@B16-molecules-24-02330]\]. These were found possessing interesting properties, for example as agrochemicals, antiparasitics and in the field of pharmacology. Additionally, in the previous studies of Scots pine bacterial endophytes, they have been shown to produce efficient antioxidant and antimicrobial compounds \[[@B17-molecules-24-02330]\]. Water extraction has been previously found effective in yielding bioactive principles from microorganisms. For example, water-soluble nucleosides, exopolysaccharides, peptides, proteins and sterols showed also bioactive properties in the caterpillar parasitic fungus *Cordyceps sinensis* \[[@B18-molecules-24-02330]\].

In this study, we explored three common endophytic fungal isolates from conifer roots and their aqueous extracts using LC--MS methodologies. The endophytic fungal species used in this study were isolated from the roots of eight-year-old Scots pine seedlings growing in a Finnish drained peatland setting. The growth conditions for trees and especially young seedlings in drained peatlands are harsh due to the extreme variability in temperature, solar radiation, variability in soil ground water level (drought/flood) and poor nutrition. The northern peatlands are rather unexplored environments as regards their endophytes. Scots pine is one of the most economically important and common tree species in Finland and the boreal zone in general. In spite of that, a limited number of studies has been published about its endophytic symbionts. In fact, to our knowledge, this is the first time that the metabolic profile of water extracted Scots pine root associated endophytic fungi belonging to DSE is investigated. However, under this kind of continuously strenuous growth conditions, the associated endophytes may play a role in enhancing the survival of the host trees by producing effective metabolites with interesting bioactivities. Moreover, we decided to use UPLC--Orbitrap--MS as UPLC enables fast and sensitive analyses with ultra-high performance for complex samples, and Orbitrap has a high resolving power and is thereby suitable for the accurate mass measurements and characterization of compounds.

2. Results and Discussion {#sec2-molecules-24-02330}
=========================

2.1. Identification of the Endophytic Fungal Isolates {#sec2dot1-molecules-24-02330}
-----------------------------------------------------

The taxonomic identification of the isolated fungal strains (A, R, and S16) was made by comparing the ITS (Internal Transcribed Spacer) region with the best GenBank Blast matches ([Table 1](#molecules-24-02330-t001){ref-type="table"}). According to the DNA sequencing of ITS1, 5.8S and ITS2 rDNA regions, A and R strains belong to PAC. ITS region of the S16 strain matched with the two species *Humicolopsis cephalosporioides* and *Coniochaeta mutabilis*. The alignments of the S16 strain together with its best GenBank matches are presented in [Supplementary Figure S1](#app1-molecules-24-02330){ref-type="app"}. PAC species cannot be reliably separated using only the ITS regions which emphasizes the need for complementing sequencing methods in order to validate the results \[[@B11-molecules-24-02330]\]. However, the strain A had 100% identity together with *Acephala applanata* strain (AY078147.1), whereas strain R was more similar with *Phialocephala fortinii* strains (see alignments in [Supplementary Figure S2](#app1-molecules-24-02330){ref-type="app"}). *Humicolopsis cephalosporioides* and *Coniochaeta mutabilis* can be considered as DSE-like fungi \[[@B19-molecules-24-02330]\]. Previously, *Coniochaeta* were considered as *Lecytophora* sp. \[[@B20-molecules-24-02330]\]. The phylogenetic tree ([Figure 1](#molecules-24-02330-f001){ref-type="fig"}) is rooted with *Coniochaeta mutabilis*. Fungal species used in this study are to be joined into the microbe and yeast library collection of Natural Resources Institute Finland.

2.2. Identification of the Metabolites {#sec2dot2-molecules-24-02330}
--------------------------------------

We were able to identify 220 metabolites from three fungal extracts ([Table 2](#molecules-24-02330-t002){ref-type="table"}) and 98 compounds were left unidentified ([Supplementary Table S1](#app1-molecules-24-02330){ref-type="app"}). Identification was mainly based on the exact masses and the molecular formula observed. It was performed with Thermo Compound Discoverer software and SciFinder Scholar database with the substance role Occurrence and the highest number of references to scale down possible compound hits. Compound Discoverer hits were also run through SciFinder database to verify that the identified products have been found in natural sources. The references shown in [Table 2](#molecules-24-02330-t002){ref-type="table"} were used to complement the identification and additionally 39 authentic standards were examined. Metabolites, whose presence and identity were verified with authentic standards, are marked with the reliability of three stars. The majority of the identified metabolites belonged to the group of amino acids, dipeptides and peptides. In addition to the main metabolites, minor ones were also present but the intensity limit of the peaks in the ion chromatogram was set at 1 × 10^7^, and the peaks with intensities lower than that were not included.

### 2.2.1. Amino Acids, Dipeptides and Peptides {#sec2dot2dot1-molecules-24-02330}

Amino acids, dipeptides and tripeptides are the most abundant group of identified metabolites in [Table 2](#molecules-24-02330-t002){ref-type="table"}, as can be expected with water extraction. With the used *m/z* range 150--2000, we were able to detect five amino acids: arginine, valine, tyrosine, phenylalanine and tryptophan ([Figure 2](#molecules-24-02330-f002){ref-type="fig"}). All except valine were verified with authentic standards and their retention time order is similar to that found in the literature \[[@B23-molecules-24-02330],[@B24-molecules-24-02330],[@B55-molecules-24-02330]\]. Valine was detected by the \[2M + H\]^+^ ion as its molecular weight is too low for the scan range used. Arginine was found to be the most dominant compound and it was detected with multiple retention times and the intensities up to 1 × 10^9^ in the mass spectrum. It was also detected as a degradation product of many peptides or other structures with arginine backbone, which explains the multiple retention times. Amino acids formed potassium adducts and \[2M + H\]^+^ and \[2M − H\]^−^ ions were also observed for them. In addition, arginine was detected by \[3M + H\]^+^ and \[3M − H\]^⁻^ ions and tryptophan with ammonium fragment ions.

Dipeptides were the most abundant class of compounds in our samples ([Table 2](#molecules-24-02330-t002){ref-type="table"}) with 122 possible identifications, which represents 55% of the identified metabolites. Out of the dipeptides, 16 were verified with autentic standards ([Figure 3](#molecules-24-02330-f003){ref-type="fig"}). In addition, three tentative identifications of cyclic dipeptides were made using databases and listed references in [Table 2](#molecules-24-02330-t002){ref-type="table"}: Cyclo(Glu-Tyr); Cyclo(3-OH-Pro-Tyr) and Cyclo(Glu-Leu) or Cyclo(Glu-Ile). Plant associated microorganisms are known to produce a variety of N-containing compounds, such as cyclic peptides and peptides \[[@B6-molecules-24-02330],[@B83-molecules-24-02330],[@B84-molecules-24-02330],[@B101-molecules-24-02330]\].

Furthermore, 29 tripeptides and other oligopeptides were tentatively identified in our samples ([Table 2](#molecules-24-02330-t002){ref-type="table"}) together with 14 amino acid derivatives. Small peptides and amino acids have also been identified from the tubers of *Pinellia ternate* roots \[[@B26-molecules-24-02330]\] and some of the findings confirm the retention order of the compounds identified by databases and literature in our study. For some compounds, additional ions were detected. Ammonium adducts were typical for aceglutamide and acetylcitrulline type compounds and the sodium adduct was detected for acetylleucine and acetylisoleucine. Glutathione yielded an additional doubly charged ion. It is a peptide produced in response to several stress situations in endophytic microbes \[[@B17-molecules-24-02330],[@B65-molecules-24-02330]\]. Its retention order in comparison to acetylcarnitine, tyrosine, adenosine, phenylalanine and tryptophan is the same as reported by Ibanez et al. \[[@B55-molecules-24-02330]\]. Additional ions of tryptophan and its ammonium fragment were detected for acetyltryptophan and for Trp-Ala dipeptide, which strengthens the tentative identifications. The retention order of arginine, dimethylarginine, tyrosine and tryptophan was similar to that found in Liang et al. \[[@B25-molecules-24-02330]\]. Dimethylarginine was also detected with ESI--MS by Gamal--Eldin et al. \[[@B33-molecules-24-02330]\]. In addition, methionine and its derivatives, such as acetylmethionine have an important role in the biochemistry of plan tissues \[[@B86-molecules-24-02330]\].

The proteins and enzymes produced by the endophytes have been reported to increase thermostability, pH-stability, UV tolerance and products with activity against pathogenic microorganisms \[[@B6-molecules-24-02330]\]. Peptides produced by the endophytes have also been searched for new antibiotic compounds and other bioactive properties \[[@B102-molecules-24-02330],[@B103-molecules-24-02330]\]. Antimicrobial peptides and proteins have been found to be biosynthesized immediately in response to pathogenic microorganism assault \[[@B104-molecules-24-02330],[@B105-molecules-24-02330],[@B106-molecules-24-02330]\]. In this study, we detected large amounts of arginine, which is commonly used as nitrogen storage because it has the highest nitrogen to carbon ratio out of all 21 proteinogenic amino acids \[[@B107-molecules-24-02330]\]. Nitrogen is often a limiting resource for the plant growth since it is needed for nucleic acid and protein synthesis. Arginine is used in the production of nitric oxide and polyamines in plants as well and both play a crucial role in the responses to abiotic and biotic stress \[[@B107-molecules-24-02330]\]. One of the cyclic dipeptides found, Cyclo(3-OH-Pro-Tyr) was reported with acaricidal activity against *Tetranychus urticae* and cyclic dipeptides have been described being active towards plant pathogens \[[@B84-molecules-24-02330],[@B108-molecules-24-02330]\].

### 2.2.2. Opine Amino Acids {#sec2dot2dot2-molecules-24-02330}

Four possible identifications in [Table 2](#molecules-24-02330-t002){ref-type="table"} were opines or N^2^-(1-carboxyethyl)-amino acids. Heliopine is a conjugate of glutamine and pyruvate, whereas rideopine is a product of the reductive amination of polyamine putrescine with α-ketoglutaric acid \[[@B34-molecules-24-02330]\]. Lysopine is a condensation product of lysine and pyruvate \[[@B43-molecules-24-02330]\]. Heliopine, rideopine and lysopine have all been detected from crown gall tumours produced by rhizosphere bacteria *Agrobacterium tumefaciens* \[[@B34-molecules-24-02330],[@B43-molecules-24-02330]\]. Valinopine has been detected from a poisonous mushroom *Clitocybe acromelalga* and is suggested being a fungal toxin \[[@B92-molecules-24-02330]\]. In addition, we were able to observe a compound tentatively identified as saccharopine, which is a precursor of lysine in the fungal α-aminoadipate pathway \[[@B109-molecules-24-02330]\]. However, the intensities were under 1 × 10^7^ and, thus, it was not included in [Table 2](#molecules-24-02330-t002){ref-type="table"}.

### 2.2.3. Amino Acid Quinones and Amadori Compounds {#sec2dot2dot3-molecules-24-02330}

Abenquine C or its enantiomer and Abenquine B1 and B2 are tentatively identified amino acid quinone derivatives in [Table 2](#molecules-24-02330-t002){ref-type="table"}. Abenquine C or *N*-\[4-(acetylamino)-3,6-dioxo-1,4-cyclo-hexa- dien-1-yl\]-[l]{.smallcaps}-valine and *N*-\[4-(acetylamino)-3,6-dioxo-1,4-cyclohexadien-1-yl\]-leucine (Abenquine B1) and -isoleucine (Abenquine B2) have been isolated from the rhizosphere bacteria *Streptomyces* sp. strain DB634 \[[@B69-molecules-24-02330],[@B70-molecules-24-02330]\]. Because more than one possible amino acid quinone masses were detected and they have been isolated from the rhizosphere, there is a possibility that root-colonizing fungi of the rhizosphere could produce these metabolites. However, the confidence level is putative identification.

Furthermore, Amadori compounds were detected. They are Maillard reaction products where amino acid is attached to a pentose or hexose sugar. Namely, hexosearginine, hexosevaline, pentoseproline, hexoseaminobutyric acid and deoxyhexosethreonine were among the tentatively identified compounds in [Table 2](#molecules-24-02330-t002){ref-type="table"}. Out of these, the presence of hexosearginine ([Figure 2](#molecules-24-02330-f002){ref-type="fig"}) was verified with a synthetic reference compound (purity 99%) \[[@B110-molecules-24-02330]\]. Additionally, hexosearginine's fragmentation into arginine was detected in UPLC-MS. Amadori compounds have previously been identified from fungal cultures \[[@B28-molecules-24-02330]\] and characteristic ions similar to our findings have also been detected by Davidek et al. \[[@B93-molecules-24-02330]\] and Wang et al. \[[@B29-molecules-24-02330]\]. Hexoseaminobutyric acid was detected with a shorter retention time than the hexose sugar structure as also shown by Lamberts et al. \[[@B42-molecules-24-02330]\]. Additionally, deoxyhexose amino acids have been previously detected from eukaryotic cells \[[@B79-molecules-24-02330]\].

### 2.2.4. Cholines {#sec2dot2dot4-molecules-24-02330}

Discovered cholines presented in [Table 2](#molecules-24-02330-t002){ref-type="table"} are choline-*[O]{.smallcaps}*-sulphate and glycerophosphorylcholine ([Figure 2](#molecules-24-02330-f002){ref-type="fig"}). Choline-*[O]{.smallcaps}*-sulphate has been found in relatively large amounts in fungal mycelia and has been suggested to act as a storage of sulphur, which is an essential metabolite for growth in filamentous fungi \[[@B41-molecules-24-02330],[@B44-molecules-24-02330]\]. Glycerophosphorylcholine is a part of phosphatidylcholine, which is a type of phospholipid in lecithin. Lecithin is a major component of the phospholipid membrane also found in plant tissues \[[@B41-molecules-24-02330]\]. The occurrence of both of these compounds was confirmed with authentic standards and they were observed as potassium adducts in the positive ionization. Glycerophosphorylcholine retention time with respect to arginine, tyrosine, adenosine and tryptophan was same as found by Liang et al. \[[@B25-molecules-24-02330]\].

### 2.2.5. Nucleobases, Nucleosides, Nucleotides, and their Derivatives {#sec2dot2dot5-molecules-24-02330}

Out of nucleobases, we were able to detect guanine and isoguanine or oxyadenine, which are the only ones with molecular mass over 150 Da ([Table 2](#molecules-24-02330-t002){ref-type="table"}). The identification of guanine was confirmed by an authentic standard ([Figure 2](#molecules-24-02330-f002){ref-type="fig"}). Isoguanine is a purine analog, which is formed as a result of direct oxidation of adenine \[[@B71-molecules-24-02330],[@B72-molecules-24-02330]\].

Nucleosides contain a nucleobase with a pentose sugar unit: ribose or deoxyribose. Cytidine, pseudouridine, uridine, adenosine, guanosine isomer, deoxyguanosine, methylthymidine, and deoxythymidine ([Table 2](#molecules-24-02330-t002){ref-type="table"}) were tentatively identified, and the presence of cytidine, uridine and adenosine was verified with authentic standards ([Figure 2](#molecules-24-02330-f002){ref-type="fig"}). Nucleosides were discovered to form formate adducts and \[2M − H\]^−^ cluster ions in negative ESI, and guanosine isomer also yielded a fragment ion responding to the detachment of pentose sugar unit. Methylthymidine has been used as an indicator of microbial presence in wastewaters \[[@B78-molecules-24-02330]\].

Nucleotides are nucleosides joined with at least one phosphate group. We were able to tentatively identify adenosine monophosphate (AMP) or deoxyguanosine monophosphate (dGMP), cyclic uridine monophosphate (cUMP), deoxyribose adenosine monophosphate (dAMP), cyclic adenosine diphosphate ribose (cyclic ADP-ribose), cyclic guanosine monophosphate (cGMP) and two exact masses and molecular formulae corresponding to dinucleotides ([Table 2](#molecules-24-02330-t002){ref-type="table"}). The dinucleotides exhibited a UV maximum at 258--261 nm, which in addition to the shape of the UV spectrum correlates with the literature \[[@B111-molecules-24-02330]\]. The absorption maximum in our study was, however, broader and continued until 300 nm, which is likely caused by other compounds eluting simultaneously. Cyclic nucleotides are used as signaling metabolites in almost all organisms and they regulate a vast number of cellular processes \[[@B59-molecules-24-02330],[@B60-molecules-24-02330],[@B61-molecules-24-02330],[@B62-molecules-24-02330]\]. The presence of the main fragment ion at *m/z* 152.1 was also detected with cGMP as reported in the literature \[[@B59-molecules-24-02330]\]. ADP-ribosyl groups are formed on target proteins as a response to DNA damage and poly(ADP-ribose) polymerase enzyme homologs, which catalyze the reaction, have also been found in fungi \[[@B66-molecules-24-02330]\]. In addition, nicotinamide riboside and nicotinamide adenine dinucleotide (NAD) were tentatively identified. NAD produced a fragment ion at *m/z* 540.1 in the negative ESI mode corresponding to the cleavage of nicotinamide. The retention order of the above mentioned metabolites was similar to that found in the literature \[[@B25-molecules-24-02330],[@B26-molecules-24-02330],[@B36-molecules-24-02330],[@B37-molecules-24-02330],[@B38-molecules-24-02330],[@B39-molecules-24-02330],[@B40-molecules-24-02330],[@B48-molecules-24-02330],[@B51-molecules-24-02330],[@B52-molecules-24-02330],[@B53-molecules-24-02330],[@B55-molecules-24-02330],[@B63-molecules-24-02330],[@B64-molecules-24-02330],[@B85-molecules-24-02330]\]. Shiao et al. \[[@B35-molecules-24-02330]\] detected nucleosides and nucleobases from the pathogenic fungus *Cordyceps sinensis* and their retention order is same as ours.

Additionally, sugar-nucleotides, such as uridine diphosphate (UDP)-glucose and UDP-galactose as well as UDP-galactosamine and UDP-glucosamine, were discovered ([Table 2](#molecules-24-02330-t002){ref-type="table"}). UDP-glucosamines and UDP-galactosamines are important precursors of the bacterial and fungal cell wall \[[@B49-molecules-24-02330]\]. Sugar nucleotides are donors of sugar groups in the biosynthesis of glycosides, polysaccharides and glycoconjugates, and they are abundant in microorganisms and plants \[[@B46-molecules-24-02330]\]. They also possess many important roles in fungi \[[@B47-molecules-24-02330],[@B54-molecules-24-02330]\].

### 2.2.6. Siderophores {#sec2dot2dot6-molecules-24-02330}

One exact mass corresponding to *cis*- and/or *trans*-fusarinine siderophore was found with two retention times ([Table 2](#molecules-24-02330-t002){ref-type="table"}). The *cis-* and *trans*-fusarinine backbones are very common in many fungal siderophores \[[@B75-molecules-24-02330],[@B76-molecules-24-02330]\]. Siderophores are low molecular weight compounds that are used for iron uptake and storage and they have, for example, been found to have importance in the maintenance of plant--fungi symbioses \[[@B74-molecules-24-02330],[@B77-molecules-24-02330]\]. Fungi and other microorganisms have been found to produce siderophores under aerobic growth conditions, where low iron availability is detected \[[@B75-molecules-24-02330]\]. Iron is essentially required for the growth and proliferation in both bacteria and fungi and siderophores provide cells with nutritional iron \[[@B102-molecules-24-02330]\]. In DSE fungi, it was found that these species have the ability to acidify the environment and produce siderophores to increase the micronutrient uptake to both members of the symbiont, indicating the association to be mutualistic rather than pathogenic \[[@B73-molecules-24-02330]\]. Fusarinine monomers where also discovered with characteristic formic acid and water fragment ions.

### 2.2.7. Other Common Metabolites {#sec2dot2dot7-molecules-24-02330}

Pentonic and hexonic acids in [Table 2](#molecules-24-02330-t002){ref-type="table"} were identified by their exact masses and molecular formulae according to Sun et al. \[[@B26-molecules-24-02330]\], where they had further identified the species being ribonic and gulonic acids using MS/MS data. Glycerophosphoinositol is closely related to glycerophosphorylcholine. It is found in both plants and fungi and is a major deacylation product of lipid metabolism \[[@B30-molecules-24-02330],[@B31-molecules-24-02330],[@B55-molecules-24-02330]\]. In addition, as with cholines, the potassium adduct was observed for it.

Acetyl coenzyme A is a central carbon and energy cycle metabolite, which is bulky and amphibilic and, thus, cannot readily transverse biological membranes. Acetylcarnitine is used in fungi to transport the acetyl unit \[[@B50-molecules-24-02330]\]. The retention order of acetylcarnitine in relation to tyrosine, glutathione dimer, adenosine, phenylalanine and tryptophan is also similar to that found by Ibanez et al. \[[@B55-molecules-24-02330]\].

Isocitrate and citric acid are isomers with the same molecular formula as well as methylisocitric acid and methylcitric acid. Citric acid and isocitrate are both important intermediates in the Krebs cycle, which is the metabolic route to produce energy to the eukaryotic cells, such as in plants and fungi. The presence of citric acid was confirmed with an authentic standard ([Figure 2](#molecules-24-02330-f002){ref-type="fig"}). In addition, we observed potassium adducts with both citric acid and isocitrate, which strengthened the tentative identification of isocitrate. Methylcitrate cycle catabolizes propionate in yeast and filamentous fungi \[[@B57-molecules-24-02330]\]. Propionate is produced during the catabolism of amino acids and fatty acid oxidation in higher eukaryotes and is toxic, thus, inhibiting the cell growth \[[@B112-molecules-24-02330]\]. Methylcitrate cycle metabolizes it into pyruvate, which can be used as a source of carbon \[[@B58-molecules-24-02330]\]. Methylcitric acid and methylisocitric acid are important intermediates in this cycle.

### 2.2.8. Sugars, Sugar Alcohols, Disaccharides {#sec2dot2dot8-molecules-24-02330}

The presence of mannitol and fucose ([Table 2](#molecules-24-02330-t002){ref-type="table"}) was confirmed using authentic standards ([Figure 2](#molecules-24-02330-f002){ref-type="fig"}). Mannitol is widely distributed in filamentous fungi and stored in the fungal hyphae as a carbon source \[[@B32-molecules-24-02330]\]. Fucose appears to represent a prominent feature in protein-linked glycans in the fungal kingdom \[[@B45-molecules-24-02330]\]. Additionally, disaccharides, such as the one isolated from pathogenic fungal species *Claviceps africans*, with fructofuranose and arabinose backbone \[[@B56-molecules-24-02330]\] were found. Deoxyhexoses, then again, are produced in fungi by pyranose oxidases, which have been reported among lignin-degrading fungi \[[@B68-molecules-24-02330]\] for example. Deoxyhexose yielded fragment ions corresponding to the cleavage of water, whereas dehydrohexose structure was detected by its sodium and ammonium adducts and by \[2M + H\]^+^ and \[2M − H\]^−^ ions. Dehydrohexose has also been previously reported from evergreen trees \[[@B67-molecules-24-02330]\].

### 2.2.9. Endophyte or Plant Metabolites {#sec2dot2dot9-molecules-24-02330}

Phomone A and B are enantiometric α-pyrone dimers isolated from the endophytic fungus *Phoma* sp. YN02-p-3 \[[@B81-molecules-24-02330],[@B82-molecules-24-02330]\]. Blumeoside C, which is an iridoid glucoside isolated from *Fagraea blumei* \[[@B80-molecules-24-02330]\] has the same molecular formula. Cuendet et al. \[[@B80-molecules-24-02330]\] discovered that Blumeoside A elutes later than Blumeoside C, which is in accordance with our findings ([Table 2](#molecules-24-02330-t002){ref-type="table"}).

Asperulosidic acid and its stereoisomer were isolated from the plant *Hedyotis diffusa* using water extraction \[[@B89-molecules-24-02330]\]. According to Friscic et al. \[[@B90-molecules-24-02330]\], asperulosidic acid elutes later than mannitol using reversed-phase liquid chromatography as in our study ([Table 2](#molecules-24-02330-t002){ref-type="table"}). Asperulosidic acid has also been isolated from *Vernonia cinerea* with ethanol \[[@B91-molecules-24-02330]\] and its structural isomers from *Morinda coreia* and *Saprosma scortechinii* with methanol \[[@B87-molecules-24-02330],[@B88-molecules-24-02330]\].

Furthermore, we were able to find exact masses corresponding to orsellinic acid esters, which have been isolated from the endophytic *Chaetomium* sp. fungus \[[@B16-molecules-24-02330],[@B95-molecules-24-02330],[@B96-molecules-24-02330],[@B97-molecules-24-02330]\]. However, orsellinic acid ester Globosumone B was not included in the [Table 2](#molecules-24-02330-t002){ref-type="table"} because of the chosen intensity limit 1 × 10^7^.

Two possible triterpene saponin structures were obtained with the molecular formula C~35~H~50~O~12~, one could be Dianthosaponin F, which has been isolated from *Dianthus japonicus* with methanol \[[@B98-molecules-24-02330]\], and the other Celosin F, which has been isolated from *Celosia argentea* with 50% ethanol \[[@B99-molecules-24-02330]\].

Linamarin is a cyanogenic glucoside isolated from the cassava (*Manihot esculenta*) roots \[[@B94-molecules-24-02330]\]. Ramulosin derivatives have been previously isolated from endophytic fungi *Nigrospora* sp. Present in the branches of *Garcinia nigrolineata* tree \[[@B16-molecules-24-02330],[@B100-molecules-24-02330]\].

2.3. Metabolites in Fungal Extracts {#sec2dot3-molecules-24-02330}
-----------------------------------

We conducted a qualitative study on the screening and identification of the water-soluble metabolites from the endophytic fungi extracts. There was a high number of primary metabolites in the aqueous extracts as expected. The number of identified metabolites was almost the same with all of the fungal species, and a majority of the metabolites, 141 compounds, were detected from all of the fungal extracts ([Figure 4](#molecules-24-02330-f004){ref-type="fig"}). From the extract A (*A. applanata*), we identified 177 metabolites and out of these 12 metabolites were exclusively found in fungus A ([Figure 4](#molecules-24-02330-f004){ref-type="fig"}). These twelve were all dipeptides or peptides except the nucleoside derivative 5-methoxycarbonylmethyluridine ([Table 2](#molecules-24-02330-t002){ref-type="table"}). From the extract of fungus R (*P. fortinii*) 184 metabolites were identified and 15 of the metabolites were found only in this extract. These included fucose, guanine, acetylcitrulline, disaccharides, dinucleotides, acetylleucine or acetylisoleucine, the endophytic fungi metabolite orsellinic acid ester and the plant metabolites blumeoside A and asperulosidic acid as well as dipeptides and peptides. From the extract of fungus S16 (*H. cephalosporioides* or *C. mutabilis*) we identified 177 metabolites and 16 of these were found in the S16 extract only. These included hexosevaline, pseudouridine, acetylglutamic acid, cUMP, NAD and saponin as well as Ala-Glu or Glu-Ala or heliopine and other dipeptides and peptides.

In this study, we identified a large number of water-soluble metabolites that may make a contribution to nutrient intake or stress-resistance of the host plant. Many of the identified compounds have been previously reported possessing interesting bioactivities. Thus, the bioactive properties of the fungal isolates and their sub-fractions are to be investigated in the future for their antimicrobial and antioxidant properties to evaluate their potential for the host plant vitality and other applications. To our knowledge, this is the first time that metabolic profiling is conducted on these Scots pine associated endophytic fungi species using water extracts. Thus, this work offers valuable reference about the metabolites of similar endophytes, which are to be discovered in the future.

3. Materials and Methods {#sec3-molecules-24-02330}
========================

3.1. Reagents {#sec3dot1-molecules-24-02330}
-------------

Ala-Phe, Ala-Tyr, Asp-Phe (methyl ester), Leu-Leu (acetate), Leu-Pro (hydrochloride), Phe-Ala, Pro-Gly, Pro-Leu, Tyr-Ala, Val-Tyr, guanine, cytidine, uridine, guanosine (hydrate), β-(--)-adenosine, [d]{.smallcaps}-mannitol, [l]{.smallcaps}-tyrosine, [l]{.smallcaps}-arginine (hydrochloride), [l]{.smallcaps}-phenylalanine, [l]{.smallcaps}-(--)-fucose and *trans*-3-indoleacrylic acid were obtained from Sigma-Aldrich (Saint Louis, MO, USA) each with purity ≥98%. [l]{.smallcaps}-α-Glycerophosphorylcholine (purity 99%) and Choline-*[O]{.smallcaps}*-sulphate (D13, purity 98%) were purchased from Carbosynth Limited, Compton, UK. [DL]{.smallcaps}-Ala-[DL]{.smallcaps}-Leu (purity ≥95%), [DL]{.smallcaps}-Ala-[DL]{.smallcaps}-Met, [DL]{.smallcaps}-Ala-[DL]{.smallcaps}-Val, [l]{.smallcaps}-Ala-[l]{.smallcaps}-Gln (HPLC grade), [l]{.smallcaps}-Ala-[l]{.smallcaps}-Trp, [l]{.smallcaps}-Ala-[l]{.smallcaps}-Pro (purity \>96%), Gly-[l]{.smallcaps}-Ile (purity \>99%), Gly-[DL]{.smallcaps}-Leu, Gly-[l]{.smallcaps}-Phe (HPLC grade), Gly-[l]{.smallcaps}-Pro (HPLC grade), [DL]{.smallcaps}-Leu-Gly, [l]{.smallcaps}-Leu-[l]{.smallcaps}-Tyr, [DL]{.smallcaps}-Leu-[DL]{.smallcaps}-Val, [l]{.smallcaps}-Leu-[l]{.smallcaps}-Ala (hydrate), and Salicin (HPLC grade) were obtained from TCI Europe, Zwijndrecht, Belgium, with purity \>98% unless specified. [l]{.smallcaps}-(--)-tryptophan (purity \>99%) was purchased from Acros Organics/Thermo Fisher Scientific, Waltham, MA, USA. Hydrogen peroxide and citric acid (monohydrate, purity \>99%) were obtained from Merck KGaA, Darmstadt, Germany, and ethanol from Altia, Helsinki, Finland.

3.2. Endophytic Fungi Isolation and Identification {#sec3dot2-molecules-24-02330}
--------------------------------------------------

The fungal endophytes were originally isolated from the roots of eight-year-old Scots pine (*Pinus sylvestris* L.) trees grown on a drained peatland forest site in western Finland. Scots pine roots were washed and the root tips were examined under a dissecting microscope. The root tips showing signs of potential fungal association or mycorrhizal features were selected for surface sterilization with a short bath in 70% ethanol and 30% H~2~O~2~ and followed by laying on sterile Petri dishes on agar. The pure cultures of the fungus mycelium were cultivated on a solid Hagem agar \[[@B113-molecules-24-02330]\] on Petri dishes.

The species of the fungus isolates were identified with molecular methods. DNA from the fungus mycelium was extracted using E.Z.N.A. Fungal DNA Mini Kit (Omega bio-tek, Norcross, GA, USA) according to the manufacturer's instructions. The nucleotide sequence of the Internal Transcribed Spacer (ITS) region of fungal ribosomal DNA (rDNA) was analysed in Macrogen Inc. (Amsterdam) from polymerase chain reaction (PCR) product amplified with ITS1 and ITS4 primer pair \[[@B114-molecules-24-02330]\]. The reaction mixture of 50 µL included, 10x enzyme buffer (Biotools B&M Labs, S.A. Madrid, Spain), 0.5 µM each primers, 0.2 µM dNTP mix, DNA Polymerase (5 U/µL) (Biotools B&M Labs, S.A. Madrid, Spain) and 1 µL DNA template. The PCR were performed with the following conditions: initial incubation at 94 °C for 5 min followed by 25 cycles of 1 min at 94 °C, 1 min at 58 °C and 1.5 min at 72 °C. Sequences with a similarity of \>99% to ITS1, 5.8S and ITS2 rDNA regions were considered as identical species \[[@B115-molecules-24-02330]\]. ITS1, 5.8S and ITS2 regions were extracted from the fungal ITS sequences and the cleaned sequences were used for BLAST searches against GenBank/NCBI to provide taxonomic identification. The best matches from GenBank were aligned and a phylogenetic tree was generated in Geneious 6.0.6 using the Neighbor-Joining analysis ([Figure 1](#molecules-24-02330-f001){ref-type="fig"}). The sequences were deposited in GenBank with accession numbers KM068384, KJ649992 and KJ649998.

3.3. Fungal Extract Preparation {#sec3dot3-molecules-24-02330}
-------------------------------

The fungal mass was collected from the surface of a cellophane membrane on agar \[[@B113-molecules-24-02330]\] with a scalpel, stored at −80 °C, and ground in a mortar before adding to sealed, sterile and previously weighed polypropylene test tubes (BD Falcon™, VWR International Oy, Helsinki, Finland). The extraction was executed with boiling deionized and filtered (0.2 µm, Nylon 66 Filter Membrane from Supelco by Sigma--Aldrich Co, Saint Louis, MO, USA) water. The fungal mass was mixed with equal amount of boiling deionized and filtered (0.45 µm Nylon membrane, Supelco Analytical/Sigma Aldrich, Saint Louis, MO, USA) water (1 mL = 1 g) by vortexing. Extraction tubes were then shaken in +95--100 °C water bath (SW22, JULABO Labortechnik GmbH, Seelbach, Germany) for 15 minutes after which the tubes were cooled in an ice bath before vortexing again. Extraction tubes were then centrifuged at +4 °C and 8200 g for 10 minutes (Eppendorf Centrifuge 5804R, Hamburg, Germany). The supernatants were collected into new polypropylene tubes and centrifuged again with the same settings. Finally, the supernatants were filtered through nylon syringe filters (0.2 µm, Cronus Filter from SMI--LabHut Ltd., Gloucester, UK) to new polypropylene tubes. Aliquots of water without fungal material were extracted simultaneously as control samples. The pH of the extracts was measured with indicator paper (scale 1--14) and it ranged from 5.5 to 7. Extracts were dried with freeze-drying equipment (VirTis BenchTop 6K with Trivac E2, D 2,5E Vacuum pump, SP Industries, Warminster, PA, USA) before storing at −80 °C. The dried extracts were dissolved in sterile purified water before analysis.

3.4. UHPLC-DAD-ESI-Orbitrap-MS {#sec3dot4-molecules-24-02330}
------------------------------

After vacuum drying, 20 µL of ethanol and 980 µL of water were added to the samples. The samples were then mixed with a vortex and filtered using 0.2 µm PTFE syringe filter prior to analyses. The samples were analyzed using an ultra-high performance liquid chromatograph coupled to a photodiode array detector (UHPLC--DAD, Acquity UPLC, Waters Corporation, Milford, MA, USA) and a hybrid quadrupole-Orbitrap mass spectrometer (Q Exactive™, Thermo Fisher Scientific GmbH, Bremen, Germany). The column was Acquity UPLC^®^ BEH Phenyl (100 × 2.1 mm i.d.; 1.7 µm; Waters Corporation, Wexford, Ireland). The mobile phase consisted of (A) acetonitrile and (B) water and formic acid (99.9:0.1, The elution profile was as follows: 0--0.5 min, 0.1% A; 0.5--5.0 min, 0.1--30% A (linear gradient); 5.0--5.1 min, 30--90% A (linear gradient); 5.1--7.1 min, 90% A; 7.1--7.2 min, 90--0.1% A (linear gradient); 7.2--8.5 min, 0.1% A. The injection volume was 5 µL and flow rate 0.5 mL/min. The UV data was collected at 190--500 nm. The heated ESI source (H--ESI II, Thermo Fisher Scientific GmbH, Bremen, Germany) was operated both in negative and positive ion modes. The parameters for negative ionization were as follows: spray voltage was set at --3.0 kV, sheath gas (N~2~) flow rate at 60 (arbitrary units), aux gas (N~2~) flow rate at 20 (arbitrary units), sweep gas flow rate at 0 (arbitrary units), capillary temperature at +380 °C and S-lens RF level at 60. The parameters for positive ionization were similar, except that spray voltage was set at 3.8 kV. Orbitrap was set at a resolution of 70,000 and an automatic gain of 3 × 10^6^ was used. Masses were scanned at *m/z* 150--2000. Pierce ESI Negative Ion Calibration Solution (Thermo Fischer Scientific Inc., Waltham, MA, USA) was used to for the calibration. The data was processed with Thermo Xcalibur Qual Browser software (Version 3.0.63, Thermo Fisher Scientific Inc., Waltham, MA, USA).

3.5. Identification {#sec3dot5-molecules-24-02330}
-------------------

Orbitrap data was processed using Compound Discoverer 2.1 SP1 (Thermo-Fisher Scientific, Waltham, MA, USA). The processing flow 'Untargeted Metabolomics Workflow' was utilized. The following general settings were used for the workflow: mass tolerance = 5 ppm, intensity threshold = 30%, S/N threshold = 3, minimum peak intensity = 1 × 10^6^, maximum element counts = 100 × C, 200 × H, 10 × N, 100 × O, 10 × S and 10 × P. The following settings were used for the peak detection: filter peaks = true, maximum peak width = 0.5 min, remove singlets = true, minimum \# scans per peak = 5 and minimum \# isotopes = 1. ChemSpider and KEGG databases were used for the identification. In addition, we used SciFinder Scholar database (American Chemical Society, CAS, Columbus, OH, USA) with substance role Occurrence and highest number of references to scale down possible compound hits.

A. Käenmäki, H. Leppälammi and E. Pihlajaviita are kindly acknowledged for their technical assistance. J. Tienaho also thanks Jesús Martín and Olga Genilloud from Fundación MEDINA, Granada, Spain as well as other team members, who welcomed and guided her warmly to their daily work during her short-term scientific mission. Their help with the initial metabolite identification is also respectfully valued.

**Sample Availability:** Samples of the compounds are not available from the authors.

The following are available online. Supplementary Figure S1: Alignment of ITS region of S16 strain (KJ649998) with its best GenBank matches *Coniochaeta mutabilis* (DQ93680) and *Humicolopsis cephalosporioides* (KC128659). Supplementary Figure S2: Alignment of ITS region of A (KM068384) and R (KJ649992) strains with their best GenBank matches *Acephala applanata* (AY078147) and *Phialocephala fortinii* (AB671499.2 and AY033087), respectively. Supplementary Table S1: The unidentified metabolites.
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![The Neighbor-Joining topology of ITS1, 5.8S and ITS2 rDNA sequences of root endophyte strains A, R and S16 from Scots pine and those obtained from GenBank. The phylogenetic tree was rooted with the *Coniochaeta mutabilis*.](molecules-24-02330-g001){#molecules-24-02330-f001}
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![A Venn diagram of the 220 identified metabolites and how they are distributed among the fungal species A (*A. applanata*), R (*P. fortinii*) and S16 (*H. cephalosporioides* or *C. mutabilis*).](molecules-24-02330-g004){#molecules-24-02330-f004}

molecules-24-02330-t001_Table 1

###### 

The endophytic fungus isolates and NCBI information about the best match and our identification.

  Strain (GenBank Accession NO.)   GenBank Accession NO. for the Best Match   Max Identity (%)/Query Coverage (%)   Our Description for the Strain     Order             Class           Phylum
  -------------------------------- ------------------------------------------ ------------------------------------- ---------------------------------- ----------------- --------------- ------------
  A (KM068384)                     AY078147.1                                 100/98                                *Acephala applanata*               Helotiales        Leotiomycetes   Ascomycota
  R (KJ649992)                     AB671499.2                                 100/100                               *Phialocephala fortinii*           Helotiales        Leotiomycetes   Ascomycota
  S16 (KJ649998)                   KC128659                                   99/98                                 *Humicolopsis cephalosporioides*                                     Ascomycota
  DQ93680                          99/98                                      *Coniochaeta mutabilis*               Coniochaetales                     Sordariomycetes   Ascomycota      

molecules-24-02330-t002_Table 2

###### 

The identified metabolites from the aqueous endophytic fungi extracts. Metabolomics Standards Initiative (MSI) was used to define the metabolite identification confidence \[[@B21-molecules-24-02330],[@B22-molecules-24-02330]\]. Level 1 is for confidently identified compounds, where an authentic chemical standard was analyzed under same analysis conditions. Level 2 is for putatively annotated compounds, where physicochemical properties and spectral similarities with public spectral libraries as well as listed references were used. Level 3 is for putatively annotated compound classes, where characteristic physicochemical properties or spectral similarities of compound classes are used to confirm identity. Unidentified compounds are shown in the [Supplementary Table S1](#app1-molecules-24-02330){ref-type="app"} and their identification is level 4: unidentified and unclassified but can be differentiated based upon spectral data. Listed references were used to confirm the identification for example by similar findings from natural sources and further justifications are described after the table. If the observed intensity of the metabolite in the total ion chromatogram is over 1 × 10^7^, metabolite is marked with x under the corresponding fungal extract. nd = not detected. RDB = ring-double bond equivalent.

                            Exact Mass   Error                                                                                                                                                 Fungal Extract                                                                                                                                                                                                                                            
  ----- ------ ------ ----- ------------ ----------- ------ ------------------------- ---- ------------------------------------------- ------------------------------------------------- ----- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---- ---- ----
  1     0.46   175    173   174.11199    174.11168   1.8    C~6~H~14~O~2~N~4~         2    Arginine                                    Amino acid                                        1     \[[@B23-molecules-24-02330],[@B24-molecules-24-02330],[@B25-molecules-24-02330],[@B26-molecules-24-02330]\]                                                                                                                                     x    x    x
  2     0.49   337    335   336.16316    336.16450   −4.0   C~12~H~24~O~7~N~4~        3    Hexosearginine                              Amadori                                           1     \[[@B27-molecules-24-02330],[@B28-molecules-24-02330],[@B29-molecules-24-02330]\]                                                                                                                                                               x    x    x
  3     0.51   335    333   334.06709    334.06650   1.8    C~9~H~19~O~11~P           2    Glycerophospho-inositol                     Common metabolite                                 2     \[[@B30-molecules-24-02330],[@B31-molecules-24-02330]\]                                                                                                                                                                                         x    \-   x
  4     0.52   372    370   371.22764    371.22810   −1.2   C~15~H~29~O~4~N~7~        5    Ace-Ala-Arg-Ala-NMe                         Peptide                                           2                                                                                                                                                                                                                                                     x    x    x
  5     0.53   183    181   182.07875    182.07904   −1.6   C~6~H~14~O~6~             1    Mannitol                                    Hexitol                                           1     \[[@B24-molecules-24-02330],[@B26-molecules-24-02330],[@B32-molecules-24-02330]\]                                                                                                                                                               x    x    x
  6     0.53   246    244   245.14851    245.14879   −1.1   C~9~H~19~O~3~N~5~         3    Ala-Arg or Arg-Ala                          Dipeptide                                         2                                                                                                                                                                                                                                                     \-   x    x
  7     0.54   nd     165   166.04668    166.04774   −6.4   C~5~H~10~O~6~             1    Pentonic acid                               Pentonic acid                                     3     \[[@B26-molecules-24-02330]\]                                                                                                                                                                                                                   x    x    x
  8     0.54   nd     195   196.05748    196.05831   −4.2   C~6~H~12~O~7~             1    Hexonic acid                                Hexonic acid                                      3     \[[@B26-molecules-24-02330]\]                                                                                                                                                                                                                   x    x    x
  9     0.54   218    216   217.10586    217.10626   −1.8   C~8~H~15~O~4~N~3~         3    Ala-Gln                                     Dipeptide                                         1                                                                                                                                                                                                                                                     \-   \-   x
  10    0.55   203    201   202.14253    202.14298   −2.2   C~8~H~18~O~2~N~4~         2    Dimethylarginine                            Amino acid derivative                             2     \[[@B25-molecules-24-02330],[@B33-molecules-24-02330]\]                                                                                                                                                                                         x    x    x
  11    0.55   219    217   218.08984    218.09027   −2.0   C~8~H~14~O~5~N~2~         3    Ala-Glu or Glu-Ala or Heliopine             Dipeptide or Opine amino acid                     2     \[[@B34-molecules-24-02330]\]                                                                                                                                                                                                                   \-   \-   x
  12    0.55   244    242   243.08558    243.08552   0.2    C~9~H~13~O~5~N~3~         5    Cytidine                                    Nucleoside                                        1     \[[@B25-molecules-24-02330],[@B26-molecules-24-02330],[@B35-molecules-24-02330],[@B36-molecules-24-02330],[@B37-molecules-24-02330],[@B38-molecules-24-02330],[@B39-molecules-24-02330],[@B40-molecules-24-02330]\]                             x    x    x
  13    0.55   248    246   247.11641    247.11682   −1.7   C~9~H~17~O~5~N~3~         3    Gln-Thr or Thr-Gln                          Dipeptide                                         2                                                                                                                                                                                                                                                     \-   \-   x
  14    0.55   258    nd    257.10240    257.10282   −1.6   C~8~H~20~O~6~NP           1    Glycerophosphoryl-choline                   Choline                                           1     \[[@B25-molecules-24-02330],[@B41-molecules-24-02330]\]                                                                                                                                                                                         x    x    x
  15    0.56   191    189   190.09479    190.09536   −3.0   C~7~H~14~O~4~N~2~         2    Ala-Thr or Thr-Ala                          Dipeptide                                         2                                                                                                                                                                                                                                                     x    x    x
  16    0.56   235°   nd    234.15747    234.15796   −2.1   C~10~H~22~O~4~N~2~        1    Valine                                      Amino acid                                        2     \[[@B23-molecules-24-02330],[@B24-molecules-24-02330],[@B26-molecules-24-02330]\]                                                                                                                                                               \-   x    x
  17    0.56   253    251   252.12182    252.12224   −1.7   C~11~H~16~O~3~N~4~        6    His-Pro or Pro-His                          Dipeptide                                         2                                                                                                                                                                                                                                                     x    x    x
  18    0.56   266    264   265.11662    265.11615   1.8    C~10~H~19~O~7~N           2    Hexoseaminobutyric acid                     Amadori                                           3     \[[@B42-molecules-24-02330]\]                                                                                                                                                                                                                   x    x    \-
  19    0.57   205    203   204.11052    204.11101   −2.4   C~8~H~16~O~4~N~2~         2    Ser-Val or Val-Ser                          Dipeptide                                         2                                                                                                                                                                                                                                                     \-   x    x
  20    0.58   187    185   186.10007    186.10044   −2.0   C~8~H~14~O~3~N~2~         3    Pro-Ala                                     Dipeptide                                         2                                                                                                                                                                                                                                                     \-   \-   x
  21    0.58   198    196   197.07971    197.08004   −1.7   C~8~H~11~O~3~N~3~         5    Acetylhistidine                             Amino acid derivative                             2                                                                                                                                                                                                                                                     \-   x    x
  22    0.58   219    217   218.12640    218.12666   −1.2   C~9~H~18~O~4~N~2~         2    Dipeptide^a^ or Lysopine or Rideopine       Dipeptide or Opine amino acid                     3/2   \[[@B34-molecules-24-02330],[@B43-molecules-24-02330]\]                                                                                                                                                                                         x    x    x
  23    0.58   246    244   245.13727    245.13756   −1.2   C~10~H~19~O~4~N~3~        3    Dipeptide^b^                                Dipeptide                                         3                                                                                                                                                                                                                                                     x    x    x
  24    0.58   260    258   259.18913    259.18959   −1.8   C~12~H~25~O~3~N~3~        2    Dipeptide^c^                                Dipeptide                                         3                                                                                                                                                                                                                                                     x    x    x
  25    0.59   184    nd    183.05615    183.05653   −2.1   C~5~H~13~O~4~NS           2    Choline-*O*-sulphate                        Choline                                           1     \[[@B41-molecules-24-02330],[@B44-molecules-24-02330]\]                                                                                                                                                                                         x    x    x
  26    0.60   233    231   232.10553    232.10592   −1.7   C~9~H~16~O~5~N~2~         3    Asp-Val or Val-Asp                          Dipeptide                                         2                                                                                                                                                                                                                                                     x    x    x
  27    0.60   335    333   334.06584    334.06650   −2.0   C~9~H~19~O~11~P           2    Glycerophospho-inositol                     Common metabolite                                 2     \[[@B30-molecules-24-02330],[@B31-molecules-24-02330]\]                                                                                                                                                                                         x    x    x
  28    0.61   165    163   164.06831    164.06848   −1.0   C~6~H~12~O~5~             1    Fucose                                      Hexose                                            1     \[[@B45-molecules-24-02330]\]                                                                                                                                                                                                                   \-   x    \-
  29    0.64   191    189   190.09482    190.09536   −2.8   C~7~H~14~O~4~N~2~         2    Ala-Thr or Thr-Ala                          Dipeptide                                         2                                                                                                                                                                                                                                                     x    x    \-
  30    0.64   219    217   218.12619    218.12666   −2.2   C~9~H~18~O~4~N~2~         2    Dipeptide^a^ or Lysopine or Rideopine       Dipeptide or Opine amino acid                     3/2   \[[@B34-molecules-24-02330],[@B43-molecules-24-02330]\]                                                                                                                                                                                         \-   x    x
  31    0.64   219    217   218.08980    218.09027   −2.2   C~8~H~14~O~5~N~2~         3    Ala-Glu or Glu-Ala or Heliopine             Dipeptide or Opine amino acid                     2     \[[@B34-molecules-24-02330]\]                                                                                                                                                                                                                   \-   \-   x
  32    0.64   nd     565   566.05592    566.05502   1.6    C~15~H~24~O~17~N~2~P~2~   8    UDP-galactose                               Nucleotide sugar                                  2     \[[@B46-molecules-24-02330],[@B47-molecules-24-02330]\]                                                                                                                                                                                         x    x    x
  33    0.65   217    215   216.12187    216.12224   −1.7   C~8~H~16~O~3~N~4~         3    Acetylarginine                              Amino acid derivative                             2     \[[@B26-molecules-24-02330]\]                                                                                                                                                                                                                   x    x    x
  34    0.66   255    nd    254.08980    254.09027   −1.8   C~11~H~14~O~5~N~2~        6    Nicotinamide riboside                       Pyridine nucleoside                               2     \[[@B48-molecules-24-02330]\]                                                                                                                                                                                                                   x    x    \-
  35    0.67   152    150   151.04916    151.04941   −1.7   C~5~H~5~ON~5~             6    Guanine                                     Nucleobase                                        1     \[[@B35-molecules-24-02330],[@B38-molecules-24-02330]\]                                                                                                                                                                                         \-   x    \-
  36    0.67   247    245   246.12114    246.12157   −1.7   C~10~H~18~O~5~N~2~        3    Dipeptide^d^                                Dipeptide                                         3                                                                                                                                                                                                                                                     x    x    x
  37    0.68   219    217   218.08995    218.09027   −1.5   C~8~H~14~O~5~N~2~         3    Ala-Glu or Glu-Ala or Heliopine             Dipeptide or Opine amino acid                     2     \[[@B34-molecules-24-02330]\]                                                                                                                                                                                                                   \-   \-   x
  38    0.68   608    606   607.08235    607.08157   1.3    C~17~H~28~O~17~N~3~P~2~   8    UDP-galactosamine                           Nucleotide sugar                                  2     \[[@B45-molecules-24-02330],[@B49-molecules-24-02330]\]                                                                                                                                                                                         x    x    x
  39    0.69   247    245   246.12112    246.12157   −1.8   C~10~H~18~O~5~N~2~        3    Dipeptide^d^                                Dipeptide                                         3                                                                                                                                                                                                                                                     x    x    x
  40    0.69   288    286   287.19514    287.19574   −2.1   C~12~H~25~O~3~N~5~        3    Dipeptide^e^                                Dipeptide                                         3                                                                                                                                                                                                                                                     x    x    x
  41    0.71   189    187   188.07948    188.07971   −1.2   C~7~H~12~O~4~N~2~         3    Aceglutamide                                Amino acid derivative                             2                                                                                                                                                                                                                                                     x    x    x
  42    0.72   193    191   192.02628    192.02701   −3.8   C~6~H~8~O~7~              4    Isocitrate                                  Common metabolite                                 2     \[[@B50-molecules-24-02330]\]                                                                                                                                                                                                                   x    x    x
  43    0.72   280    278   279.13127    279.1318    −1.9   C~11~H~21~O~7~N           2    Hexosevaline                                Amadori                                           2     \[[@B28-molecules-24-02330],[@B29-molecules-24-02330]\]                                                                                                                                                                                         \-   \-   x
  44    0.73   246    244   245.13705    245.13756   −2.1   C~10~H~19~O~4~N~3~        3    Dipeptide^b^                                Dipeptide                                         3                                                                                                                                                                                                                                                     x    x    x
  45    0.74   348    346   347.06239    347.06309   −2.0   C~10~H~14~O~7~N~5~P       8    AMP or dGMP                                 Nucleotide                                        2     \[[@B51-molecules-24-02330],[@B52-molecules-24-02330],[@B53-molecules-24-02330]\]                                                                                                                                                               \-   x    x
  46    0.74   nd     565   566.05580    566.05502   1.4    C~15~H~24~O~17~N~2~P~2~   8    UDP-glucose                                 Nucleotide sugar                                  2     \[[@B46-molecules-24-02330],[@B47-molecules-24-02330],[@B53-molecules-24-02330],[@B54-molecules-24-02330]\]                                                                                                                                     x    x    x
  47    0.77   204    nd    203.11554    203.11576   −1.1   C~9~H~17~O~4~N            2    Acetylcarnitine                             Common metabolite                                 2     \[[@B50-molecules-24-02330],[@B55-molecules-24-02330]\]                                                                                                                                                                                         x    x    x
  48    0.77   219    217   218.12622    218.12666   −2.0   C~9~H~18~O~4~N~2~         2    Dipeptide^a^ or Lysopine or Rideopine       Dipeptide or Opine amino acid                     3/2   \[[@B34-molecules-24-02330],[@B43-molecules-24-02330]\]                                                                                                                                                                                         x    x    x
  49    0.77   333    331   332.13261    332.13320   −1.8   C~12~H~2~O~7~N~4~         5    Tripeptide/peptide^f^                       Tripeptide or peptide                             3                                                                                                                                                                                                                                                     x    x    \-
  50    0.78   205    203   204.11084    204.11101   −0.8   C~8~H~16~O~4~N~2~         2    Ser-Val or Val-Ser                          Dipeptide                                         2                                                                                                                                                                                                                                                     x    x    x
  51    0.78   608    606   607.08248    607.08157   1.5    C~17~H~27~O~17~N~3~P~2~   8    UDP-glucoseamine                            Nucleotide sugar                                  2     \[[@B46-molecules-24-02330],[@B49-molecules-24-02330]\]                                                                                                                                                                                         x    x    x
  52    0.80   187    185   186.10017    186.10044   −1.5   C~8~H~14~O~3~N~2~         3    Ala-Pro                                     Dipeptide                                         1     \[[@B26-molecules-24-02330]\]                                                                                                                                                                                                                   x    x    x
  53    0.80   193    191   192.02628    192.02701   −3.8   C~6~H~8~O~7~              4    Citric acid                                 Common metabolite                                 1     \[[@B24-molecules-24-02330],[@B26-molecules-24-02330]\]                                                                                                                                                                                         x    x    x
  54    0.80   260    258   259.18922    259.18959   −1.4   C~12~H~26~O~3~N~3~        2    Dipeptide^c^                                Dipeptide                                         3                                                                                                                                                                                                                                                     x    x    x
  55    0.80   315    313   314.12205    314.1213    2.4    C~11~H~22~O~10~           1    Disaccharide                                Disaccharide                                      3     \[[@B56-molecules-24-02330]\]                                                                                                                                                                                                                   \-   x    \-
  56    0.81   189    187   188.11563    188.11609   −2.4   C~8~H~16~O~3~N~2~         2    Dipeptide^g^                                Dipeptide                                         3                                                                                                                                                                                                                                                     x    x    x
  57    0.81   288    286   287.19523    287.19574   −1.8   C~12~H~25~O~3~N~5~        3    Dipeptide^e^                                Dipeptide                                         3                                                                                                                                                                                                                                                     \-   x    x
  58    0.81   333    331   332.13261    332.13320   −1.8   C~12~H~20~O~7~N~4~        5    Tripeptide/peptide^f^                       Tripeptide or peptide                             3                                                                                                                                                                                                                                                     x    x    \-
  59    0.82   219    217   218.12630    218.12666   −1.7   C~9~H~18~O~4~N~2~         2    Dipeptide^a^ or Lysopine or Rideopine       Dipeptide or Opine amino acid                     3/2   \[[@B34-molecules-24-02330],[@B43-molecules-24-02330]\]                                                                                                                                                                                         x    \-   x
  60    0.84   260    258   259.15272    259.15321   −1.9   C~11~H~21~O~4~N~3~        3    Di-/Tripeptide^h^                           Di-/Tripeptide                                    3                                                                                                                                                                                                                                                     x    x    x
  61    0.85   219    217   218.12633    218.12666   −1.5   C~9~H~18~O~4~N~2~         2    Dipeptide^a^ or Lysopine or Rideopine       Dipeptide or Opine amino acid                     3     \[[@B34-molecules-24-02330],[@B43-molecules-24-02330]\]                                                                                                                                                                                         x    x    x
  62    0.85   233    231   232.14192    232.14231   −1.7   C~10~H~20~O~4~N~2~        2    Dipeptide^i^                                Dipeptide                                         3                                                                                                                                                                                                                                                     x    x    x
  63    0.85   260    258   259.18870    259.18959   −3.4   C~12~H~26~O~3~N~3~        2    Dipeptide^c^                                Dipeptide                                         3                                                                                                                                                                                                                                                     x    x    x
  64    0.86   221    219   220.08778    220.08817   −1.8   C~8~H~16~O~3~N~2~S        2    Cys-Val or Val-Cys or Met-Ala               Dipeptide                                         2                                                                                                                                                                                                                                                     x    x    x
  65    0.86   245    243   244.06948    244.06954   −0.2   C~9~H~12~O~6~N~2~         5    Pseudouridine                               Nucleoside                                        2     \[[@B25-molecules-24-02330],[@B35-molecules-24-02330]\]                                                                                                                                                                                         \-   \-   x
  66    0.86   247    245   246.12114    246.12157   −1.7   C~10~H~18~O~5~N~2~        3    Dipeptide^d^                                Dipeptide                                         3                                                                                                                                                                                                                                                     x    x    x
  67    0.87   182    180   181.07374    181.07389   −0.8   C~9~H~11~O~3~N            5    Tyrosine                                    Amino acid                                        1     \[[@B23-molecules-24-02330],[@B24-molecules-24-02330],[@B25-molecules-24-02330],[@B26-molecules-24-02330],[@B55-molecules-24-02330]\]                                                                                                           x    x    x
  68    0.87   nd     205   206.04209    206.04266   −2.8   C~7~H~10~O~7~             3    Methylisocitric acid                        Common metabolite                                 2     \[[@B57-molecules-24-02330],[@B58-molecules-24-02330]\]                                                                                                                                                                                         x    x    x
  69    0.89   260    258   259.15288    259.15321   −1.3   C~11~H~21~O~4~N~3~        3    Di-/Tripeptide^h^                           Di-/Tripeptide                                    3                                                                                                                                                                                                                                                     x    x    \-
  70    0.91   190    188   189.06334    189.06372   −2.0   C~7~H~11~O~5~N            3    Acetylglutamic acid                         Amino acid derivative                             2                                                                                                                                                                                                                                                     \-   x    x
  71    0.91   233    231   232.14152    232.14231   −3.4   C~10~H~20~O~4~N~2~        2    Dipeptide^i^                                Dipeptide                                         3                                                                                                                                                                                                                                                     x    x    x
  72    0.91   260    258   259.18907    259.18959   −2.0   C~12~H~26~O~3~N~3~        2    Dipeptide^c^                                Dipeptide                                         3                                                                                                                                                                                                                                                     x    x    x
  73    0.93   233    231   232.10574    232.10592   −0.8   C~9~H~16~O~5~N~2~         3    Asp-Val or Val-Asp                          Dipeptide                                         2                                                                                                                                                                                                                                                     x    x    x
  74    0.95   nd     205   206.04215    206.04266   −2.5   C~7~H~10~O~7~             4    Methylcitric acid                           Common metabolite                                 2     \[[@B57-molecules-24-02330],[@B58-molecules-24-02330]\]                                                                                                                                                                                         x    x    x
  75    0.95   218    216   217.10599    217.10626   −1.2   C~8~H~15~O~4~N~3~         3    Acetylcitrulline                            Amino acid derivative                             2                                                                                                                                                                                                                                                     \-   x    \-
  76    0.97   190    188   189.06359    189.06372   −0.7   C~7~H~11~O~5~N            3    Acetylglutamic acid                         Amino acid derivative                             2                                                                                                                                                                                                                                                     \-   \-   x
  77    0.97   307    305   306.02467    306.02530   −2.1   C~9~H~11~O~8~N~2~P        7    2',3'-cUMP or 3',5'-cUMP                    Nucleotide                                        2     \[[@B59-molecules-24-02330],[@B60-molecules-24-02330],[@B61-molecules-24-02330],[@B62-molecules-24-02330]\]                                                                                                                                     \-   \-   x
  78    0.99   245    243   244.06915    244.06954   −1.6   C~9~H~12~O~6~N~2~         5    Uridine                                     Nucleoside                                        1     \[[@B35-molecules-24-02330],[@B36-molecules-24-02330],[@B38-molecules-24-02330],[@B39-molecules-24-02330],[@B63-molecules-24-02330]\]                                                                                                           x    x    x
  79    0.99   288    286   287.19481    287.19574   −3.2   C~12~H~25~O~3~N~5~        3    Dipeptide^e^                                Dipeptide                                         3                                                                                                                                                                                                                                                     x    x    x
  80    0.99   332    330   331.06749    331.06817   −2.0   C~10~H~14~O~6~N~5~P       8    dAMP                                        Nucleotide                                        2     \[[@B52-molecules-24-02330],[@B53-molecules-24-02330],[@B64-molecules-24-02330]\]                                                                                                                                                               \-   x    x
  81    1.01   253    251   252.11056    252.11101   −1.8   C~12~H~16~O~4~N~2~        6    Ala-Tyr                                     Dipeptide                                         1                                                                                                                                                                                                                                                     x    x    x
  82    1.03   261    259   260.13679    260.13722   −1.6   C~11~H~20~O~5~N~2~        3    Dipeptide^j^                                Dipeptide                                         3                                                                                                                                                                                                                                                     x    x    x
  83    1.04   203    201   202.13162    202.13174   −0.6   C~9~H~18~O~3~N~2~         2    Leu-Ala                                     Dipeptide                                         1                                                                                                                                                                                                                                                     x    x    x
  84    1.04   215    213   214.13141    214.13174   −1.5   C~10~H~18~O~3~N~2~        3    Pro-Val or Val-Pro                          Dipeptide                                         2                                                                                                                                                                                                                                                     x    x    x
  85    1.08   221    219   220.08783    220.08817   −1.5   C~8~H~16~O~3~N~2~S        2    Cys-Val or Val-Cys or Met-Ala               Dipeptide                                         2                                                                                                                                                                                                                                                     x    x    x
  86    1.10   261    259   260.13679    260.13722   −1.6   C~11~H~20~O~5~N~2~        3    Dipeptide^j^                                Dipeptide                                         3                                                                                                                                                                                                                                                     x    x    x
  87    1.10   664    662   663.10777    663.10912   −2.0   C~21~H~27~O~14~N~7~P~2~   15   Nicotinamide adenine dinucleotide           Dinucleotide                                      2     \[[@B48-molecules-24-02330]\]                                                                                                                                                                                                                   \-   \-   x
  88    1.11   260    258   259.15306    259.15321   −0.6   C~11~H~21~O~4~N~3~        3    Di-/Tripeptide^h^                           Di-/Tripeptide                                    3                                                                                                                                                                                                                                                     x    \-   \-
  89    1.17   202    nd    201.11101    201.11134   −1.6   C~8~H~15~O~3~N~3~         3    Acetylmethyl-glutaminamide                  Amino acid derivative                             2                                                                                                                                                                                                                                                     x    \-   \-
  90    1.17   403    401   402.22194    402.22268   −1.8   C~16~H~30~O~6~N~6~        5    Tripeptide/peptide^k^                       Tripeptide or peptide                             3                                                                                                                                                                                                                                                     x    \-   \-
  91    1.18   613    611   612.15080    612.15197   −1.9   C~20~H~32~O~12~N~6~S~2~   8    Glutathione dimer                           Tripeptide                                        2     \[[@B17-molecules-24-02330],[@B55-molecules-24-02330],[@B65-molecules-24-02330]\]                                                                                                                                                               x    \-   x
  92    1.23   315    313   314.12193    314.12130   2.0    C~11~H~22~O~10~           1    Disaccharide                                Disaccharide                                      3     \[[@B56-molecules-24-02330]\]                                                                                                                                                                                                                   x    x    \-
  93    1.24   189    187   188.11571    188.11609   −2.0   C~8~H~16~O~3~N~2~         2    Dipeptide^g^                                Dipeptide                                         3                                                                                                                                                                                                                                                     x    x    x
  94    1.24   269    267   268.10536    268.10592   −2.1   C~12~H~16~O~5~N~2~        6    Ser-Tyr or Tyr-Ser                          Dipeptides                                        2                                                                                                                                                                                                                                                     x    x    x
  95    1.30   268    266   267.09608    267.09676   −2.5   C~10~H~13~O~4~N~5~        7    Adenosine                                   Nucleoside                                        1     \[[@B25-molecules-24-02330],[@B26-molecules-24-02330],[@B35-molecules-24-02330],[@B36-molecules-24-02330],[@B37-molecules-24-02330],[@B38-molecules-24-02330],[@B40-molecules-24-02330],[@B55-molecules-24-02330],[@B63-molecules-24-02330]\]   x    x    x
  96    1.33   315    313   314.12166    314.12130   1.2    C~11~H~22~O~10~           1    Disaccharide                                Disaccharide                                      3     \[[@B56-molecules-24-02330]\]                                                                                                                                                                                                                   \-   x    \-
  97    1.33   542    540   541.05998    541.06111   −2.1   C~15~H~21~O~13~N~5~P~2~   11   Cyclic ADP-ribose                           Nucleotide                                        2     \[[@B66-molecules-24-02330]\]                                                                                                                                                                                                                   x    x    \-
  98    1.40   179    177   178.04742    178.04774   −1.8   C~6~H~10~O~6~             2    Dehydrohexose                               Dehydro-hexose                                    3     \[[@B67-molecules-24-02330]\]                                                                                                                                                                                                                   x    x    x
  99    1.42   221    219   220.08820    220.08817   0.1    C~8~H~16~O~3~N~2~S        2    Ala-Met                                     Dipeptide                                         1                                                                                                                                                                                                                                                     \-   \-   x
  100   1.47   346    344   345.04695    345.04744   −1.4   C~10~H~12~O~7~N~5~P       9    2',3'-cGMP or 3',5'-cGMP                    Nucleotide                                        2     \[[@B25-molecules-24-02330],[@B38-molecules-24-02330],[@B51-molecules-24-02330],[@B59-molecules-24-02330],[@B60-molecules-24-02330],[@B61-molecules-24-02330],[@B62-molecules-24-02330]\]                                                       x    x    x
  101   1.48   219    217   218.12633    218.12666   −1.5   C~9~H~18~O~4~N~2~         2    Dipeptide^a^ or Lysopine or Rideopine       Dipeptide or Opine amino acid                     2/3   \[[@B34-molecules-24-02330],[@B43-molecules-24-02330]\]                                                                                                                                                                                         x    x    x
  102   1.50   267    265   266.12611    266.12666   −2.1   C~13~H~18~O~4~N~2~        6    Dipeptide^l^                                Dipeptide                                         3                                                                                                                                                                                                                                                     x    x    x
  103   1.50   284    282   283.09056    283.09167   −3.9   C~10~H~13~O~5~N~5~        7    Guanosine isomer                            Nucleoside                                        2     \[[@B26-molecules-24-02330],[@B35-molecules-24-02330],[@B37-molecules-24-02330],[@B39-molecules-24-02330]\]                                                                                                                                     x    x    x
  104   1.54   346    344   345.04701    345.04744   −1.2   C~10~H~12~O~7~N~5~P       9    2',3'-cGMP or 3',5'-cGMP                    Nucleotide                                        2     \[[@B25-molecules-24-02330],[@B38-molecules-24-02330],[@B51-molecules-24-02330],[@B59-molecules-24-02330],[@B60-molecules-24-02330],[@B61-molecules-24-02330],[@B62-molecules-24-02330]\]                                                       x    \-   x
  105   1.57   165    163   164.06821    164.06848   −1.6   C~6~H~12~O~5~             1    Deoxyhexose                                 Deoxyhexose                                       3     \[[@B68-molecules-24-02330]\]                                                                                                                                                                                                                   x    x    \-
  106   1.61   246    244   245.13713    245.13756   −1.7   C~10~H~19~O~4~N~3~        3    Dipeptide^b^                                Dipeptide                                         3                                                                                                                                                                                                                                                     x    x    x
  107   1.64   219    217   218.12628    218.12666   −1.7   C~9~H~18~O~4~N~2~         2    Dipeptide^a^ or Lysopine or Rideopine       Dipeptide or Opine amino acid                     3/2   \[[@B34-molecules-24-02330],[@B43-molecules-24-02330]\]                                                                                                                                                                                         x    x    x
  108   1.64   267    265   266.12620    266.12666   −1.7   C~13~H~18~O~4~N~2~        6    Dipeptide^l^                                Dipeptide                                         3                                                                                                                                                                                                                                                     x    x    x
  109   1.67   260    258   259.15294    259.15321   −1.0   C~11~H~21~O~4~N~3~        3    Di-/Tripeptide^h^                           Di-/Tripeptide                                    3                                                                                                                                                                                                                                                     x    x    x
  110   1.68   294    292   293.13692    293.13756   −2.2   C~14~H~19~O~4~N~3~        7    Di/tripeptide^m^                            Di-/Tripeptide                                    3                                                                                                                                                                                                                                                     x    x    x
  111   1.69   233    231   232.14200    232.14231   −1.3   C~10~H~20~O~4~N~2~        2    Dipeptide^i^                                Dipeptide                                         3                                                                                                                                                                                                                                                     x    x    x
  112   1.71   281    279   280.10530    280.10592   −2.2   C~13~H~16~O~5~N~2~        7    Abenquine C or enantiomer                   AA quinone                                        2     \[[@B69-molecules-24-02330],[@B70-molecules-24-02330]\]                                                                                                                                                                                         x    x    x
  113   1.72   189    187   188.11572    188.11609   −2.0   C~8~H~16~O~3~N~2~         2    Dipeptide^g^                                Dipeptide                                         3                                                                                                                                                                                                                                                     x    x    x
  114   1.74   152    150   151.04925    151.04941   −1.0   C~5~H~5~ON~5~             6    Isoguanine or Oxyadenine                    Nucleobase                                        2     \[[@B71-molecules-24-02330],[@B72-molecules-24-02330]\]                                                                                                                                                                                         \-   x    x
  115   1.74   246    244   245.13727    245.13756   −1.2   C~10~H~19~O~4~N~3~        3    Dipeptide^b^                                Dipeptide                                         3                                                                                                                                                                                                                                                     x    x    x
  116   1.74   279    277   278.12642    278.12666   −0.9   C~14~H~18~O~4~N~2~        7    Pro-Tyr or Tyr-Pro                          Dipeptide                                         2                                                                                                                                                                                                                                                     x    x    x
  117   1.74   288    286   287.19527    287.19574   −1.6   C~12~H~25~O~3~N~5~        3    Dipeptide^e^                                Dipeptide                                         3                                                                                                                                                                                                                                                     \-   \-   x
  118   1.75   261    259   260.13698    260.13722   −0.9   C~11~H~20~O~5~N~2~        3    Fusarinine monomer                          Siderophore                                       2     \[[@B73-molecules-24-02330],[@B74-molecules-24-02330],[@B75-molecules-24-02330],[@B76-molecules-24-02330],[@B77-molecules-24-02330]\]                                                                                                           x    x    x
  119   1.75   268    266   267.09639    267.09676   −1.4   C~10~H~13~O~4~N~5~        7    Deoxyguanosine                              Nucleoside                                        2     \[[@B35-molecules-24-02330]\]                                                                                                                                                                                                                   x    x    x
  120   1.75   318    316   317.15840    317.15869   −0.9   C~13~H~23~O~6~N~3~        4    Tripeptide/peptide^n^                       Tripeptide/ peptide                               3                                                                                                                                                                                                                                                     x    x    x
  121   1.76   166    164   165.07893    165.07898   −0.3   C~9~H~11~O~2~N            5    Phenylalanine                               Amino acid                                        1     \[[@B23-molecules-24-02330],[@B24-molecules-24-02330],[@B26-molecules-24-02330],[@B55-molecules-24-02330]\]                                                                                                                                     x    x    x
  122   1.76   189    187   188.11574    188.11609   −1.8   C~8~H~16~O~3~N~2~         2    Dipeptide^g^                                Dipeptide                                         3                                                                                                                                                                                                                                                     \-   \-   x
  123   1.76   260    258   259.15306    259.15321   −0.6   C~11~H~21~O~4~N~3~        3    Di-/Tripeptide^h^                           Di-/Tripeptide                                    3                                                                                                                                                                                                                                                     x    x    x
  124   1.78   257    255   256.10554    256.10592   −1.5   C~11~H~16~O~5~N~2~        5    Methylthymidine                             Nucleoside derivative                             2     \[[@B78-molecules-24-02330]\]                                                                                                                                                                                                                   x    x    x
  125   1.78   266    264   265.11577    265.11615   −1.4   C~10~H~19~O~7~N           2    Deoxyhexose-threonine                       Amadori                                           3     \[[@B79-molecules-24-02330]\]                                                                                                                                                                                                                   x    x    \-
  126   1.80   203    201   202.13164    202.13174   −0.5   C~9~H~18~O~3~N~2~         2    Ala-Leu                                     Dipeptide                                         1                                                                                                                                                                                                                                                     x    x    x
  127   1.80   260    258   259.15303    259.15321   −0.7   C~11~H~21~O~4~N~3~        3    Di-/Tripeptide^h^                           Di-/Tripeptide                                    3                                                                                                                                                                                                                                                     x    x    x
  128   1.82   189    187   188.11586    188.11609   −1.2   C~8~H~16~O~3~N~2~         2    Dipeptide^g^                                Dipeptide                                         3                                                                                                                                                                                                                                                     x    x    x
  129   1.82   215    213   214.13157    214.13174   −0.8   C~10~H~18~O~3~N~2~        3    Pro-Val or Val-Pro                          Dipeptide                                         2                                                                                                                                                                                                                                                     x    x    x
  130   1.82   233    231   232.14207    232.14231   −1.0   C~10~H~20~O~4~N~2~        2    Dipeptide^i^                                Dipeptide                                         3                                                                                                                                                                                                                                                     x    x    x
  131   1.85   307    305   306.02538    306.02530   0.3    C~9~H~11~O~8~N~2~P        7    2',3'-cUMP or 3',5'-cUMP                    Nucleotide                                        2     \[[@B59-molecules-24-02330],[@B60-molecules-24-02330],[@B61-molecules-24-02330],[@B62-molecules-24-02330]\]                                                                                                                                     x    x    x
  132   1.86   260    258   259.15312    259.15321   −0.3   C~11~H~21~O~4~N~3~        3    Di-/Tripeptide^h^                           Di-/Tripeptide                                    3                                                                                                                                                                                                                                                     x    \-   x
  133   1.86   348    346   347.16926    347.16925   0.0    C~14~H~25~O~7~N~3~        4    Tripeptide^o^                               Tripeptide                                        3                                                                                                                                                                                                                                                     x    \-   \-
  134   1.87   249    247   248.11934    248.11947   −0.5   C~10~H~20~O~3~N~2~S       2    Met-Val or Val-Met                          Dipeptide                                         2                                                                                                                                                                                                                                                     x    x    x
  135   1.89   261    259   260.13682    260.13722   −1.5   C~11~H~20~O~5~N~2~        3    Fusarinine monomer                          Siderophore                                       2     \[[@B73-molecules-24-02330],[@B74-molecules-24-02330],[@B75-molecules-24-02330],[@B76-molecules-24-02330],[@B77-molecules-24-02330]\]                                                                                                           x    x    x
  136   1.89   281    279   280.14177    280.14231   −1.9   C~14~H~20~O~4~N~2~        6    Val-Tyr                                     Dipeptide                                         1                                                                                                                                                                                                                                                     x    x    x
  137   1.89   295    293   294.12105    294.12157   −1.8   C~14~H~18~O~5~N~2~        7    Peptide type compound^p^                    Dipeptide or peptide derivative                   3     \[[@B69-molecules-24-02330],[@B70-molecules-24-02330]\]                                                                                                                                                                                         x    x    x
  138   1.90   318    316   317.15846    317.15869   −0.7   C~13~H~23~O~6~N~3~        4    Tripeptide/peptide^n^                       Tripeptide/ peptide                               3                                                                                                                                                                                                                                                     x    \-   \-
  139   1.90   317    315   316.09129    316.09067   2.0    C~12~H~16~O~8~N~2~        7    5-methoxycarbonyl-methyluridine             Nucleoside derivative                             2     \[[@B39-molecules-24-02330],[@B40-molecules-24-02330]\]                                                                                                                                                                                         x    \-   \-
  140   1.91   229    227   228.14731    228.14739   −0.3   C~11~H~20~O~3~N~2~        3    Pro-Leu                                     Dipeptide                                         1                                                                                                                                                                                                                                                     x    x    x
  141   1.91   247    245   246.12143    246.12157   −0.6   C~10~H~18~O~5~N~2~        3    Dipeptide^d^                                Dipeptide                                         3                                                                                                                                                                                                                                                     x    x    x
  142   1.95   249    247   248.11934    248.11947   −0.5   C~10~H~20~O~3~N~2~S       2    Met-Val or Val-Met                          Dipeptide                                         2                                                                                                                                                                                                                                                     x    x    x
  143   1.96   231    229   230.16318    230.16304   0.6    C~11~H~22~O~3~N~2~        2    Dipeptide^q^                                Dipeptide                                         3                                                                                                                                                                                                                                                     x    x    x
  144   1.96   237    235   236.11595    236.11609   −0.6   C~12~H~16~O~3~N~2~        6    Ala-Phe                                     Dipeptide                                         1                                                                                                                                                                                                                                                     x    x    x
  145   1.96   348    346   347.16933    347.16925   0.2    C~14~H~25~O~7~N~3~        4    Tripeptide^o^                               Tripeptide                                        3                                                                                                                                                                                                                                                     x    x    \-
  146   1.99   223    221   222.10043    222.10044   0.0    C~11~H~14~O~3~N~2~        6    Gly-Phe                                     Dipeptide                                         1                                                                                                                                                                                                                                                     x    x    x
  147   1.99   246    244   245.13786    245.13756   1.2    C~10~H~19~O~4~N~3~        3    Dipeptide^b^                                Dipeptide                                         3                                                                                                                                                                                                                                                     x    \-   \-
  148   2.02   541    539   540.14854    540.14791   1.2    C~24~H~28~O~14~           11   Phomone A or B or Blumeoside C              Endophyte or plant metabolite                     2     \[[@B80-molecules-24-02330],[@B81-molecules-24-02330],[@B82-molecules-24-02330]\]                                                                                                                                                               \-   x    x
  149   2.06   355    353   354.15419    354.15394   0.7    C~15~H~22~O~6~N~4~        7    Peptide^r^                                  Peptide                                           3                                                                                                                                                                                                                                                     \-   \-   x
  150   2.07   581    579   580.15391    580.15436   −0.8   C~20~H~25~O~9~N~10~P      15   Dinucleotide                                Dinucleotide                                      3                                                                                                                                                                                                                                                     \-   x    \-
  151   2.08   229    227   228.14738    228.14739   0.0    C~11~H~20~O~3~N~2~        3    Ile-Pro or Pro-Ile                          Dipeptide                                         2                                                                                                                                                                                                                                                     x    x    x
  152   2.09   231    229   230.16290    230.16304   −0.6   C~11~H~22~O~3~N~2~        2    Dipeptide^q^                                Dipeptide                                         3                                                                                                                                                                                                                                                     x    x    x
  153   2.10   247    245   246.12100    246.12157   −2.3   C~10~H~18~O~5~N~2~        3    Dipeptide^d^                                Dipeptide                                         3                                                                                                                                                                                                                                                     x    x    x
  154   2.10   306    304   305.13731    305.13756   −0.8   C~15~H~19~O~4~N~3~        8    Thr-Trp or Trp-Thr                          Dipeptide                                         2                                                                                                                                                                                                                                                     x    x    x
  155   2.10   581    579   580.15428    580.15436   −0.1   C~20~H~25~O~9~N~10~P      15   Dinucleotide                                Dinucleotide                                      3                                                                                                                                                                                                                                                     \-   x    \-
  156   2.14   318    316   317.15843    317.15869   −0.8   C~13~H~23~O~6~N~3~        4    Tripeptide/peptide^n^                       Tripeptide/ peptide                               3                                                                                                                                                                                                                                                     x    x    x
  157   2.15   253    251   252.11087    252.11101   −0.5   C~12~H~16~O~4~N~2~        6    Phe-Ser or Ser-Phe                          Dipeptide                                         2     \[[@B55-molecules-24-02330]\]                                                                                                                                                                                                                   x    x    x
  158   2.15   279    277   278.12630    278.12666   −1.3   C~14~H~18~O~4~N~2~        7    Pro-Tyr or Tyr-Pro                          Dipeptide                                         2                                                                                                                                                                                                                                                     x    x    x
  159   2.19   455    453   454.15532    454.15560   −0.6   C~16~H~30~O~7~N~4~S~2~    4    Peptide^s^                                  Peptide                                           3                                                                                                                                                                                                                                                     x    x    \-
  160   2.20   280    278   279.12166    279.12191   −0.9   C~13~H~17~O~4~N~3~        7    Di/tripeptide^t^                            Di-/Tripeptide                                    3                                                                                                                                                                                                                                                     x    x    x
  161   2.20   318    316   317.15861    317.15869   −0.2   C~13~H~23~O~6~N~3~        4    Tripeptide/peptide^n^                       Tripeptide/ peptide                               3                                                                                                                                                                                                                                                     x    x    x
  162   2.22   229    227   228.14723    228.14739   −0.7   C~11~H~20~O~3~N~2~        3    Leu-Pro                                     Dipeptide                                         1                                                                                                                                                                                                                                                     x    x    x
  163   2.22   345    343   344.13676    344.13722   −1.3   C~18~H~20~O~5~N~2~        10   Tyr-Tyr                                     Dipeptide                                         2                                                                                                                                                                                                                                                     x    x    x
  164   2.22   348    346   347.16899    347.16925   −0.7   C~14~H~25~O~7~N~3~        4    Tripeptide^o^                               Tripeptide                                        3                                                                                                                                                                                                                                                     x    \-   \-
  165   2.24   223    221   222.10048    222.10044   0.2    C~11~H~14~O~3~N~2~        6    Phe-Gly                                     Dipeptide                                         2                                                                                                                                                                                                                                                     x    x    x
  166   2.26   277    275   276.11095    276.11101   −0.2   C~14~H~16~O~4~N~2~        8    Peptide type compound^u^                    Dipeptide/ cyclodipeptide                         3     \[[@B83-molecules-24-02330],[@B84-molecules-24-02330]\]                                                                                                                                                                                         x    x    x
  167   2.27   294    292   293.13713    293.13756   −1.5   C~14~H~19~O~4~N~3~        7    Di/tripeptide^m^                            Di-/Tripeptide                                    3                                                                                                                                                                                                                                                     x    x    x
  168   2.27   295    293   294.15724    294.15796   −2.4   C~15~H~22~O~4~N~2~        6    Leu-Tyr                                     Dipeptide                                         1                                                                                                                                                                                                                                                     x    x    x
  169   2.28   247    245   246.12108    246.12157   −2.0   C~10~H~18~O~5~N~2~        3    Dipeptide^d^                                Dipeptide                                         3                                                                                                                                                                                                                                                     x    x    x
  170   2.29   231    229   230.16275    230.16304   −1.2   C~11~H~22~O~3~N~2~        2    Dipeptide^q^                                Dipeptide                                         3                                                                                                                                                                                                                                                     x    x    x
  171   2.29   237    235   236.11557    236.11609   −2.2   C~12~H~16~O~3~N~2~        6    Gly-Phe or Phe-Gly methyl ester             Dipeptide derivative                              2                                                                                                                                                                                                                                                     x    x    x
  172   2.30   267    265   266.12630    266.12666   −1.3   C~13~H~18~O~4~N~2~        6    Dipeptide^l^                                Dipeptide                                         3                                                                                                                                                                                                                                                     x    x    x
  173   2.32   229    227   228.14734    228.14739   −0.2   C~11~H~20~O~3~N~2~        3    Ile-Pro or Pro-Ile                          Dipeptide                                         2                                                                                                                                                                                                                                                     x    x    x
  174   2.32   557    555   556.15074    556.14283   14.2   C~24~H~28~O~15~           11   Blumeoside A                                Plant metabolite                                  2     \[[@B80-molecules-24-02330]\]                                                                                                                                                                                                                   \-   x    \-
  175   2.34   205    203   204.08986    204.08988   −0.1   C~11~H~12~O~2~N~2~        7    Tryptophan                                  Amino acid                                        1     \[[@B23-molecules-24-02330],[@B24-molecules-24-02330],[@B25-molecules-24-02330],[@B26-molecules-24-02330],[@B55-molecules-24-02330]\]                                                                                                           x    x    x
  176   2.34   227    225   226.09527    226.09536   −0.4   C~10~H~14~O~4~N~2~        5    Deoxythymidine                              Nucleoside                                        2     \[[@B85-molecules-24-02330]\]                                                                                                                                                                                                                   x    \-   x
  177   2.34   263    261   262.13484    262.13512   −1.1   C~11~H~22~O~3~N~2~S       2    Dipeptide^v^                                Dipeptide                                         3                                                                                                                                                                                                                                                     x    x    x
  178   2.35   261    259   260.13704    260.13722   −0.7   C~11~H~20~O~5~N~2~        3    Dipeptide^j^                                Dipeptide                                         3                                                                                                                                                                                                                                                     x    x    x
  179   2.37   295    293   294.15764    294.15796   −1.1   C~15~H~22~O~4~N~2~        6    Dipeptide^w^                                Dipeptide                                         3                                                                                                                                                                                                                                                     x    x    x
  180   2.38   281    279   280.10551    280.10592   −1.5   C~13~H~16~O~5~N~2~        7    Abenquine C or enantiomer                   AA quinone                                        2     \[[@B69-molecules-24-02330],[@B70-molecules-24-02330]\]                                                                                                                                                                                         x    x    x
  181   2.39   277    275   276.11095    276.11101   −0.2   C~14~H~16~O~4~N~2~        8    Peptide type compound^u^                    Dipeptide/ cyclodipeptide                         3     \[[@B83-molecules-24-02330],[@B84-molecules-24-02330]\]                                                                                                                                                                                         x    x    x
  182   2.39   295    293   294.12163    294.12157   0.2    C~14~H~18~O~5~N~2~        7    Peptide type compound^p^                    Dipeptide or peptide derivative                   3     \[[@B69-molecules-24-02330],[@B70-molecules-24-02330]\]                                                                                                                                                                                         x    x    x
  183   2.40   160    158   159.08949    159.08954   −0.3   C~7~H~13~O~3~N            2    Acetylvaline                                Amino acid derivative                             2     \[[@B26-molecules-24-02330]\]                                                                                                                                                                                                                   x    x    \-
  184   2.41   276    274   275.12709    275.12699   0.4    C~14~H~17~O~3~N~3~        8    Ala-Trp                                     Dipeptide                                         1                                                                                                                                                                                                                                                     x    x    x
  185   2.45   261    259   260.13728    260.13722   0.2    C~11~H~20~O~5~N~2~        3    Dipeptide^j^                                Dipeptide                                         3                                                                                                                                                                                                                                                     x    x    x
  186   2.45   263    261   262.13499    262.13512   −0.5   C~11~H~22~O~3~N~2~S       2    Dipeptide^v^                                Dipeptide                                         3                                                                                                                                                                                                                                                     x    x    x
  187   2.46   295    293   294.15803    294.15796   0.2    C~15~H~22~O~4~N~2~        6    Dipeptide^w^                                Dipeptide                                         3                                                                                                                                                                                                                                                     x    x    x
  188   2.50   281    279   280.10603    280.10592   0.4    C~13~H~16~O~5~N~2~        7    α-Asp-Phe                                   Dipeptide                                         1                                                                                                                                                                                                                                                     x    x    x
  189   2.54   245    243   244.17876    244.17869   0.3    C~12~H~24~O~3~N~2~        2    Leu-Leu                                     Dipeptide                                         1                                                                                                                                                                                                                                                     x    x    x
  190   2.54   281    279   280.10582    280.10592   −0.3   C~13~H~16~O~5~N~2~        7    β-Asp-Phe                                   Dipeptide                                         1                                                                                                                                                                                                                                                     x    x    \-
  191   2.55   263    261   262.13402    262.13512   −4.2   C~11~H~22~O~3~N~2~S       2    Dipeptide^v^                                Dipeptide                                         3                                                                                                                                                                                                                                                     x    x    x
  192   2.55   265    263   264.14735    264.14739   −0.1   C~14~H~20~O~3~N~2~        6    Val-Phe or Phe-Val                          Dipeptide                                         2                                                                                                                                                                                                                                                     x    x    x
  193   2.58   253    251   252.12127    252.12224   −3.8   C~11~H~16~O~3~N~4~        6    His-Pro or Pro-His                          Dipeptide                                         2                                                                                                                                                                                                                                                     x    x    x
  194   2.59   382    380   381.15388    381.15360   0.7    C~17~H~23~O~7~N~3~        8    Tripeptide^x^                               Tripeptide                                        3                                                                                                                                                                                                                                                     x    x    \-
  195   2.60   293    291   292.10606    292.10592   0.5    C~14~H~16~O~5~N~2~        8    Pyr-Tyr or Cyclo(Glu-​Tyr)​                 Dipeptide/ cyclo-dipeptide                        2     \[[@B83-molecules-24-02330]\]                                                                                                                                                                                                                   x    \-   \-
  196   2.61   192    190   191.06101    191.06162   −3.2   C~7~H~13~O~3~NS           2    Acetylmethionine                            Amino acid derivative                             2     \[[@B26-molecules-24-02330],[@B86-molecules-24-02330]\]                                                                                                                                                                                         \-   x    x
  197   2.66   281    279   280.10557    280.10592   −1.2   C~13~H~16~O~5~N~2~        7    Phe-Asp                                     Dipeptide                                         2                                                                                                                                                                                                                                                     x    x    x
  198   2.66   295    293   294.15748    294.15796   −1.6   C~15~H~22~O~4~N~2~        6    Dipeptide^w^                                Dipeptide                                         3                                                                                                                                                                                                                                                     x    \-   x
  199   2.69   263    261   262.13505    262.13512   −0.3   C~11~H~22~O~3~N~2~S       2    Dipeptide^v^                                Dipeptide                                         3                                                                                                                                                                                                                                                     x    x    x
  200   2.75   276    274   275.12715    275.12699   0.6    C~14~H~17~O~3~N~3~        8    Trp-Ala                                     Dipeptide                                         2                                                                                                                                                                                                                                                     x    x    x
  201   2.75   433    431   432.12736    432.12678   1.3    C~18~H~24~O~12~           7    Asperulosidic acid or isomer                Plant metabolite                                  2     \[[@B87-molecules-24-02330],[@B88-molecules-24-02330],[@B89-molecules-24-02330],[@B90-molecules-24-02330],[@B91-molecules-24-02330]\]                                                                                                           \-   x    \-
  202   2.75   518    516   517.23808    517.23840   −0.6   C~21~H~35~O~10~N~5~       7    Peptide^y^                                  Peptide                                           3                                                                                                                                                                                                                                                     x    x    \-
  203   2.77   306    304   305.13740    305.13756   −0.5   C~15~H~19~O~4~N~3~        8    Thr-Trp or Trp-Thr                          Dipeptide                                         2                                                                                                                                                                                                                                                     x    x    x
  204   2.78   295    293   294.12150    294.12157   −0.2   C~14~H~18~O~5~N~2~        7    Peptide type compound^p^                    Dipeptide or peptide derivative                   3     \[[@B69-molecules-24-02330],[@B70-molecules-24-02330]\]                                                                                                                                                                                         x    x    x
  205   2.81   265    263   264.14732    264.14739   −0.3   C~14~H~20~O~3~N~2~        6    Val-Phe or Phe-Val                          Dipeptide                                         2                                                                                                                                                                                                                                                     x    x    x
  206   2.91   248    246   247.10475    247.10559   −3.4   C~10~H~17~O~6~N           3    Pentoseproline or Valinopine or Linamarin   Amadori or Opine amino acid or Plant metabolite   2     \[[@B92-molecules-24-02330],[@B93-molecules-24-02330],[@B94-molecules-24-02330]\]                                                                                                                                                               x    x    x
  207   2.99   287    285   286.10512    286.10526   −0.5   C~13~H~18~O~7~            5    Orsellinic acid ester                       Endophytic fungi metabolite                       3     \[[@B16-molecules-24-02330],[@B95-molecules-24-02330],[@B96-molecules-24-02330],[@B97-molecules-24-02330]\]                                                                                                                                     \-   x    \-
  208   3.01   248    246   247.10585    247.10559   1.1    C~10~H~17~O~6~N           3    Pentoseproline or Valinopine or Linamarin   Amadori or Opine amino acid or Plant metabolite   2     \[[@B92-molecules-24-02330],[@B93-molecules-24-02330],[@B94-molecules-24-02330]\]                                                                                                                                                               x    x    x
  209   3.02   528    526   527.29613    527.29552   1.2    C~24~H~41~O~8~N~5~        7    Peptide^z^                                  Peptide                                           3                                                                                                                                                                                                                                                     \-   x    \-
  210   3.11   243    241   242.12691    242.12666   1.0    C~11~H~18~O~4~N~2~        4    Dipeptide^\#^                               Dipeptide                                         3                                                                                                                                                                                                                                                     x    \-   \-
  211   3.22   174    172   173.10513    173.10519   −0.3   C~8~H~15~O~3~N            2    Acetylleucine or acetylisoleucine           Amino acid derivative                             2     \[[@B26-molecules-24-02330]\]                                                                                                                                                                                                                   \-   x    \-
  212   3.29   243    241   242.12608    242.12666   −2.4   C~11~H~18~O~4~N~2~        4    Dipeptide^\#^                               Dipeptide                                         3                                                                                                                                                                                                                                                     x    \-   \-
  213   3.37   174    172   173.10538    173.10519   1.1    C~8~H~15~O~3~N            2    Acetylleucine or acetylisoleucine           Amino acid derivative                             2     \[[@B26-molecules-24-02330]\]                                                                                                                                                                                                                   \-   x    \-
  214   3.37   663    661   662.33214    662.33023   2.9    C~35~H~50~O~12~           11   Saponin                                     Saponin                                           3     \[[@B98-molecules-24-02330],[@B99-molecules-24-02330]\]                                                                                                                                                                                         \-   \-   x
  215   3.50   282    280   281.08955    281.08994   −1.4   C~13~H~15~O~6~N           7    Phenylacetyl-glutamine                      Amino acid derivative                             2                                                                                                                                                                                                                                                     x    x    x
  216   3.76   277    275   276.11052    276.11101   −1.8   C~14~H~16~O~4~N~2~        8    Peptide type compound^u^                    Dipeptide/ cyclodipeptide                         3     \[[@B83-molecules-24-02330],[@B84-molecules-24-02330]\]                                                                                                                                                                                         x    \-   \-
  217   4.07   517    515   516.27897    516.27685   4.1    C~19~H~36~O~7~N~10~       7    Peptide^¤^                                  Peptide                                           3                                                                                                                                                                                                                                                     \-   x    \-
  218   4.23   247    245   246.10060    246.10044   0.7    C~13~H~14~O~3~N~2~        8    Acetyltryptophan                            Amino acid derivative                             2                                                                                                                                                                                                                                                     x    \-   x
  219   4.30   397    395   396.21529    396.21212   8.0    C~17~H~28~O~5~N~6~        6    Tripeptide/peptide^§^                       Tripeptide/ peptide                               3                                                                                                                                                                                                                                                     \-   x    \-
  220   4.95   201    199   200.10441    200.10486   −2.2   C~10~H~16~O~4~            2    Ramulosin derivative                        endophytic fungi metabolite                       3     \[[@B16-molecules-24-02330],[@B100-molecules-24-02330]\]                                                                                                                                                                                        x    x    x

a = Dipeptide containing Leu or Ile and Ser or Thr and Val; b = Dipeptide containing Leu or Ile and Asn or Gln and Val; c = Dipeptide containing Leu or Ile and Lys; d = Dipeptide containing Leu or Ile and Asp or Glu and Val; e = Dipeptide containing Leu or Ile and Arg; f = Tripeptide containing Ala, Asp and Gln or Gln, Glu and Gly or Ala, Asn and Glu or a tetrapeptide containing Ala, Ala, Asp and Gly or Ala, Glu Gly and Gly or the methyl ester of acetylated tripeptide containing Asn, Gly and Ser; g = Dipeptide containing Leu or Ile and Gly or Ala and Val; h = Dipeptide containing Leu or Ile and Gln; or a tripeptide containing Ala, Gly and Leu or Ile; or Ala, Ala and Val; or the methyl ester of an acetylated dipeptide containing Gly or Ala and Lys; or the ethyl ester of Ala-Ala-Ala or a tripeptide containing Gly, Gly and Val; or an acetylated dipeptide containing Thr and Val; or the methyl ester of a tripeptide containing Gly, Gly and Leu or Ile; or the methyl ester of a dipeptide containing or Asn and Leu or Ile; or Val and Gln; or the methyl ester of a tripeptide containing Ala, Gly and Val; i = Dipeptide containing Leu or Ile and Thr; j = Dipeptide containing Leu or Ile and Glu; k = Tripeptide containing Arg, Glu and Val; or Arg, Asp and Leu or Ile; or Gln, Gln and Lys or a tetrapeptide containing Ala, Ala, Asp and Lys; or Ala, Gln, Gly and Lys or a pentapeptide containing Ala, Ala, Gly, Gly and Lys; l = Dipeptide containing Phe and Thr or the methyl ester of a dipeptide containing Phe and Ser or Ala and Tyr; or the ethyl ester of a dipeptide containing Gly and Tyr; or the phenyl methyl ester of a dipeptide containing Ala and Ser; m = Dipeptide containing Gln and Phe or a tripeptide containing Ala, Gly and Phe or the methyl ester of a dipeptide containing Asn and Phe or the methyl ester of a tripeptide containing Gly, Gly and Phe or the phenyl methyl ester of a dipeptide containing Gln and Gly or the phenyl methyl ester of a tripeptide containing Ala, Gly and Gly; n = Tripeptide containing Ala, Glu and Val; or Glu, Glu and Leu or Ile; or Pro, Thr and Thr; or Ala, Asp and Leu or Ile; or an acetylated tripeptide containing Gly, Ser and Leu and Ile; or Gly, Thr and Val; or the methyl ester of a tripeptide containing Ala, Asp and Val or Asp, Gly and Leu or Ile; o = Tripeptide containing Asp, Thr and Leu or Ile; Or Glu, Ser and Leu or Ile; or Glu, Thr and Val; or the methyl ester of a tripeptide containing Asp, Thr and Val; or an acetylated tripeptide containing Ser, Thr and Val; p = Dipeptide containing Glu and Phe or Abenquine B1 or Abenquine B2; q = Dipeptide containing Leu or Ile and Val; r = Tripeptide-amide containing Pyr, Glu and Pro; s = Tetrapeptide containing Cys, Met, Thr and Thr or Met, Met, Ser and Ser; t = Dipeptide containing Asn and Phe or a tripeptide containing Gly, Gly and Phe; or a dipeptide-amide containing Asp and Phe; or an acetylated dipeptide-amide containing Gly and Tyr or the phenyl methyl ester of Gly-Gly-Gly; u = Pyr-Phe or Cyclo(3-OH-Pro-Tyr) or Acetylmethoxy-Trp; v = Dipeptide containing Leu or Ile and Met; w = Dipeptide containing Leu or Ile and Tyr; x = Tripeptide containing Ala, Glu and Tyr; or Asp, Phe and Thr; or Glu, Phe and Ser or the methyl ester of a tripeptide containing Asp, Phe and Ser; y = Tetrapeptide containing Gln, Glu, Glu and Leu or Ile; or a pentapeptide containing Ala, Asp, Asp, Val and Val; or Asp, Pro, Ser, Ser or Leu or Ile; or Ala, Ala, Glu, Glu And Val; or Ala, Ala, Asp, Glu and Leu or Ile; or Ala, Glu, Glu, Gly and Leu or Ile; or Asp, Asp, Gly, Val and Leu or Ile; or Asp, Pro, Thr, Ser, Val; or Glu, Pro, Ser, Ser and Val; or Ala, Glu, Pro, Thr and Thr; z = Pentapeptide containing Pro, Pro, Thr, Thr and Leu or Ile; or Glu, Gly, Pro, Leu or Ile and Leu or Ile; or Ala, Asp, Pro, Leu or Ile and Leu or Ile; or Ala, Glu, Pro, Val and Leu or Ile; \# = Cyclo(Glu-Leu); or Pyr and Leu or Ile; or Pyr-Val methyl ester; ¤ = Tetrapeptide containing Ala, Arg, Arg and Asp; or Arg, Arg, Glu and Gly; or an acetylated tetrapeptide containing Arg, Arg, Gly and Ser; § = Tripeptide containing Gln, His and Leu or Ile; or a tetrapeptide containing Ala, Gly, His and Leu or Ile; or Ala, Ala, His and Val; or an acetylalted tripeptide containing Ala, His and Lys; or the methyl ester of a tripeptide containing Pyr, Arg and Pro; or a pentapeptide-amide containing Ala, Gly, Gly, Pro and Pro; ° = Is detected by the \[2M + H\]+ ion due to the used m/z range.
